data_2rr0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rr0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.845 0.355 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.17 -27.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 p -110.97 -23.0 11.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.29 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 51.1 Cg_exo -55.13 -20.15 23.11 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.665 2.243 . . . . 0.0 112.569 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -48.71 171.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.624 0.249 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -39.01 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 111.682 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -89.9 -89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -150.19 35.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 110.982 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.2 160.89 20.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -176.08 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.56 153.6 19.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -161.23 89.67 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 5.4 t0 -139.72 138.85 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.29 -59.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -143.34 -45.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.64 39.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -149.99 79.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.792 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 3.8 t80 -89.53 130.86 35.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -150.22 139.0 20.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 m -89.77 133.09 34.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.85 122.38 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 25.8 p -129.67 -164.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.572 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.42 ' HE3' ' HD2' ' A' ' 29' ' ' PRO . 3.7 tpt -89.7 140.44 28.02 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.502 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' HE3' ' A' ' 28' ' ' MET . 9.2 Cg_endo -50.53 89.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.098 2.532 . . . . 0.0 111.828 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.86 -20.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -89.63 122.63 32.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 110.366 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -102.46 -174.85 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.87 -173.84 15.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.85 -30.59 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.42 25.74 8.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.8 OUTLIER 60.41 90.16 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -177.0 42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.288 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.847 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.653 0.263 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 tt -114.33 21.38 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.302 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 m -150.1 -42.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.155 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.4 88.97 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.745 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 59.4 Cg_endo -71.92 -5.67 17.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.746 2.297 . . . . 0.0 112.9 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.1 m -56.71 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.26 -43.61 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 -91.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.061 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.12 31.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -70.53 165.45 22.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.497 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.42 171.13 8.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.74 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 p -92.24 153.84 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.111 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -158.02 77.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.7 t70 -126.57 142.11 51.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -150.07 -71.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.53 38.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 11.96 61.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.71 70.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.658 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 2.0 t80 -76.91 129.52 36.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.191 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.32 136.03 18.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.6 m -93.1 139.99 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.342 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.3 mm -99.05 121.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -124.06 -170.72 2.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.208 0.528 . . . . 0.0 112.099 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.458 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 1.6 mtp -89.65 160.49 41.44 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.424 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 9.8 Cg_endo -50.07 125.0 13.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.928 2.419 . . . . 0.0 111.668 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.19 -5.67 63.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.405 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.79 104.59 17.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.73 0.3 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.73 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.342 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.09 -169.86 13.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.431 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -89.65 -29.91 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.768 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -126.61 29.06 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.712 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.4 m 60.98 91.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.565 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -177.36 42.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.056 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.7 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.103 179.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 85.5 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.859 0.361 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 tt -92.41 -30.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.8 t -116.18 17.36 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.32 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 53.94 97.55 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 65.4 Cg_endo -72.43 -16.77 27.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.506 2.138 . . . . 0.0 112.506 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.3 m -56.55 -169.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -57.65 2.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.76 -145.88 0.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.76 53.34 2.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.95 -178.96 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.234 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -124.89 140.29 53.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -89.96 145.32 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 tp -141.41 87.8 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.013 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.67 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 14.7 t70 -90.01 150.5 22.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -126.92 -60.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.645 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.95 -63.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.837 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.17 4.52 5.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.805 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -150.22 162.33 40.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 33.1 p90 -148.82 -177.1 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.8 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 138.77 29.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.765 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -93.75 123.68 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.075 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.81 122.62 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.547 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -129.1 -165.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 8.0 mmm -89.84 128.16 51.27 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 2.0 Cg_endo -40.82 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.945 2.43 . . . . 0.0 112.267 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.04 -18.79 1.76 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.375 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.74 96.39 10.67 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.77 0.319 . . . . 0.0 110.421 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -174.89 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.47 -159.36 14.75 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.261 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 m -89.87 -36.24 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.52 30.57 5.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.577 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 62.66 76.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -150.9 41.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.86 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.808 0.337 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 tp -95.56 -32.2 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -144.76 15.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.389 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.98 112.31 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 69.6 Cg_endo -73.58 -18.05 22.9 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.431 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m -63.04 -175.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.39 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -55.52 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -89.33 -168.43 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.81 52.49 2.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.05 176.73 4.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -89.96 165.28 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.32 123.15 37.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.968 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.86 87.19 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 31.7 t70 -135.81 161.24 36.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.41 -65.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.08 -46.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.77 -33.85 0.78 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.725 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.88 106.66 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.99 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 9.7 t80 -113.06 121.51 44.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.09 141.18 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.972 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.32 155.68 18.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.8 120.59 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.046 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 p -120.98 -170.63 2.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.562 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.436 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 8.3 mmm -89.86 129.95 44.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.114 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 4.5 Cg_exo -38.81 91.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.176 2.584 . . . . 0.0 112.371 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 150.34 -24.14 1.09 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.107 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 17.1 m-30 -89.84 83.86 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.469 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -90.06 -177.1 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.11 -154.86 16.28 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.565 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.91 -30.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 1.1 m-85 -131.24 31.36 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m 54.47 74.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.93 30.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.149 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.8 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.739 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.79 0.329 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -103.45 -33.1 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -117.76 -13.32 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.454 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.62 97.36 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.61 0.243 . . . . 0.0 110.82 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -66.35 -12.95 37.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.487 2.125 . . . . 0.0 112.638 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -55.85 175.76 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.757 0.313 . . . . 0.0 110.783 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -59.44 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.76 -145.4 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.418 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.76 50.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.939 0.399 . . . . 0.0 110.827 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.26 158.62 16.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.07 163.07 15.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 p -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tt -142.65 96.54 2.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 27.7 t0 -128.06 131.79 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.51 -74.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.96 73.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.35 -29.51 11.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.96 134.71 34.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.1 t80 -134.92 141.13 46.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.975 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -150.08 131.45 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.86 129.87 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.83 121.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.486 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 p -126.93 -167.03 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.414 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.445 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 10.1 tpt -89.71 120.43 69.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.34 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 83.9 Cg_exo -33.55 95.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.223 2.615 . . . . 0.0 112.725 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.61 -12.83 2.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.52 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 28' ' ' MET . 38.9 m-85 -89.72 107.37 19.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.828 0.346 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -175.31 4.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.361 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.5 -166.63 12.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.41 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.82 -32.37 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.669 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -128.23 29.08 5.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.537 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.4 m 61.09 76.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.1 28.77 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.4 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.941 0.4 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.66 -40.29 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -138.79 18.61 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 57.08 104.37 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.1 Cg_endo -70.08 -19.22 34.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.474 2.116 . . . . 0.0 112.342 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 m -54.64 -178.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.77 -58.43 1.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.07 0.462 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -89.81 -144.94 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.508 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.81 51.94 2.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.42 147.59 24.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -90.39 157.8 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 26.5 p -91.61 151.11 20.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 87.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 17.6 t0 -127.52 150.25 49.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -132.98 -54.3 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pp -149.42 -46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.82 34.75 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -150.01 108.99 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.3 t80 -114.68 135.43 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.99 130.38 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.0 m -90.45 130.25 36.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.88 123.33 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.446 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.27 -169.72 2.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.437 . . . . 0.0 111.629 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.447 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 9.0 mmm -89.97 129.41 46.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 2.9 Cg_endo -39.63 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.2 2.6 . . . . 0.0 112.421 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 152.99 -25.7 0.81 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.25 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.1 m-30 -89.79 111.91 23.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.666 0.269 . . . . 0.0 110.463 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -110.6 -175.97 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.149 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.06 -151.4 17.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.91 -31.95 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 110.922 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.7 m-85 -133.77 28.85 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.725 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.65 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.634 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -171.0 40.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.001 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.038 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.719 0.295 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.51 HG22 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.11 -35.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.148 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -106.77 -20.1 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 62.76 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 44.7 Cg_endo -68.3 -9.74 26.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.84 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.8 m -58.85 -163.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.08 -45.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -90.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -150.12 29.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 110.67 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -70.1 162.34 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 171.41 9.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.88 124.59 49.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.89 89.14 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -113.48 168.58 9.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -150.08 -65.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.715 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -150.16 -45.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.83 -33.52 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.891 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -89.77 152.3 21.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.057 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 11.5 t80 -155.79 139.35 15.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.19 138.87 20.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.0 m -89.94 141.04 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 27.6 mm -99.51 122.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 5.2 p -119.06 -171.44 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.687 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.438 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 12.0 mmm -89.8 132.1 37.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 5.7 Cg_exo -36.49 92.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.383 2.722 . . . . 0.0 112.454 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.26 -23.28 1.56 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.184 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -89.8 122.88 33.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 110.418 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -164.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.113 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.38 -171.79 14.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.436 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.91 -32.86 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.48 24.19 11.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.33 81.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.645 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.18 49.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.179 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 54.2 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.93 -31.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.24 -21.83 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 66.11 105.88 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 80.2 Cg_endo -75.47 -25.33 11.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.604 2.203 . . . . 0.0 112.179 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.2 m -51.35 165.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.02 -56.44 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.107 0.479 . . . . 0.0 111.101 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -89.68 -143.39 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.74 59.65 4.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.91 151.32 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.975 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -95.89 167.1 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 p -95.43 157.52 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.801 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -149.12 87.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -120.93 138.63 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -122.91 -78.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -150.06 30.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.235 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.68 -37.91 0.54 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.584 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.92 133.63 34.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 110.977 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.536 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 2.0 t80 -135.94 124.43 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -150.15 141.23 23.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 135.41 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.725 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -96.25 123.08 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 7.3 p -126.99 -165.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.64 136.56 29.41 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.328 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.96 103.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.97 2.447 . . . . 0.0 112.374 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.13 -20.94 3.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.128 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.89 112.69 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.278 . . . . 0.0 110.252 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.29 -165.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -168.54 12.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.263 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 m -89.88 -29.97 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.6 m-85 -125.23 27.85 6.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 61.21 86.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.732 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.54 41.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.6 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.213 -179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.45 -31.16 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.51 -27.76 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 63.57 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 58.4 Cg_endo -70.47 -14.1 33.5 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 m -56.49 -173.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.741 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -106.55 -60.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -89.75 -147.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.5 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.68 59.56 4.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.042 0.448 . . . . 0.0 110.684 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.85 177.18 6.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.131 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 177.68 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.3 t -102.57 149.4 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 72.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -108.26 145.32 34.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -122.65 -72.26 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.3 -66.72 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.99 -27.83 3.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.589 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.94 159.01 17.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 53.1 t80 -146.35 145.88 30.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -144.44 157.92 44.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.93 127.87 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.9 mm -89.87 122.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.442 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.3 p -128.04 -168.18 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.581 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.454 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 9.7 mmm -89.83 129.88 44.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.5 Cg_exo -38.94 91.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.198 2.599 . . . . 0.0 112.383 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.29 -26.3 0.98 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.134 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.2 m-30 -89.85 117.86 29.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.327 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -118.08 -175.62 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 111.203 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.44 -152.52 16.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.86 -31.27 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -132.26 28.97 4.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.52 90.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -170.86 35.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.054 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.756 0.312 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -97.97 -34.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -101.91 -29.94 11.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 62.51 115.75 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 68.5 Cg_endo -82.44 1.54 9.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.699 2.266 . . . . 0.0 112.316 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 m -60.13 -165.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.773 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -45.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -89.98 -88.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -150.27 30.19 0.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.763 0.315 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 168.41 17.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.21 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 -165.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.23 146.2 51.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.863 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -160.71 100.66 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' HA ' ' CB ' ' A' ' 23' ' ' PHE . 4.8 p-10 -92.48 176.01 6.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -147.22 -62.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 pt -149.69 77.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.07 -48.05 2.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.37 163.14 13.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 110.819 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.614 ' CB ' ' HA ' ' A' ' 18' ' ' ASP . 1.8 p90 -155.78 -179.64 8.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -147.68 155.03 41.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 m -89.39 141.65 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.825 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 26' ' ' ILE . 1.3 mp -101.49 128.4 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.533 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.8 p -118.49 -171.6 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.152 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.427 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 3.0 tpt -89.61 137.12 28.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.9 Cg_exo -36.98 104.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.172 2.581 . . . . 0.0 112.753 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.87 -9.76 7.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.512 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.89 111.95 23.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.03 -168.15 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.75 176.07 21.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.447 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.02 -29.85 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.307 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.5 m-85 -117.68 24.92 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 57.74 82.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.96 42.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.4 mm . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.159 179.885 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.709 0.29 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -97.82 -33.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -5.35 11.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.325 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.04 118.92 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.82 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.2 Cg_endo -75.92 -22.06 13.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.533 2.156 . . . . 0.0 112.408 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.1 m -58.84 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.15 -43.43 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.401 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.88 -88.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.082 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -150.24 27.28 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.91 156.92 38.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.5 m -90.0 145.29 25.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 p -90.24 135.37 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tp -127.36 79.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.2 t0 -95.97 157.97 15.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.07 -49.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -150.0 57.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.82 -48.76 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.83 159.3 16.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.669 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.0 p90 -164.25 -178.1 5.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -146.95 136.88 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.0 129.83 37.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.811 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mm -98.86 124.59 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.738 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 4.2 p -118.47 -176.24 3.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.407 ' HE1' ' CD ' ' A' ' 29' ' ' PRO . 10.8 mmm -89.76 136.91 28.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' HE1' ' A' ' 28' ' ' MET . 14.6 Cg_exo -31.01 122.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.755 2.97 . . . . 0.0 112.77 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.02 -10.02 51.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.331 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.85 108.85 19.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.716 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -166.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.51 -176.85 18.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.545 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.01 -35.04 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.14 25.36 10.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.068 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.6 OUTLIER 59.54 78.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.47 42.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 179.843 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -108.57 -33.79 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 -17.0 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.274 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.86 100.01 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 49.8 Cg_endo -68.68 -9.52 26.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.51 2.14 . . . . 0.0 112.738 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.4 m -48.92 170.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.807 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -102.43 -48.04 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -90.04 -91.86 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.28 36.37 0.67 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.22 172.3 10.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.88 178.61 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 t -95.78 155.83 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.69 79.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.41 158.62 22.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -144.42 -82.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -146.85 83.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.67 -35.59 4.33 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.94 157.31 16.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 13.3 t80 -158.63 144.38 16.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 5.6 mt-30 -150.05 149.8 30.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.16 127.82 54.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.777 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.73 122.2 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -128.38 -158.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.421 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.463 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 8.1 tpt -89.62 133.13 34.96 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.381 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.5 Cg_exo -30.26 115.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.659 2.906 . . . . 0.0 113.003 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.2 23.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.21 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 27.6 m-85 -89.82 75.92 7.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.566 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.92 -175.73 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.41 -115.66 3.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.36 -45.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 111.411 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -127.69 31.93 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.1 t 59.41 85.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.876 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.32 34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.132 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.8 mp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.828 0.347 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -94.73 -32.05 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.1 p -136.12 12.6 3.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.306 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.18 118.15 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.9 Cg_endo -74.77 -16.7 20.68 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.466 2.111 . . . . 0.0 112.364 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -57.91 -166.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 -42.01 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.571 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -89.95 -88.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.208 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.12 43.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.978 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.84 158.28 15.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.9 158.36 15.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.714 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.03 148.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.35 74.33 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.7 t0 -95.34 131.12 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -125.4 -68.26 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.59 72.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -54.8 4.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -90.02 162.2 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 46.3 p90 -157.73 179.83 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 141.01 22.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.84 133.9 34.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.14 123.07 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.9 p -119.75 -168.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 9.4 mmm -89.58 131.88 38.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 2.9 Cg_exo -34.93 97.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.432 2.754 . . . . 0.0 112.645 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.92 -13.3 4.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.374 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.85 106.94 18.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.98 -168.23 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.82 -175.95 16.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.0 -29.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -128.7 30.55 5.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.2 m 60.79 91.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -169.73 33.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 0.0 111.088 179.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.5 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.78 0.324 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -101.29 -31.95 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -104.93 -30.78 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.83 91.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 23' ' ' PHE . 69.6 Cg_exo -51.59 -22.25 12.46 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.535 2.157 . . . . 0.0 112.578 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.9 m -45.95 164.26 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.685 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.91 -40.57 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -89.83 -94.14 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -150.24 41.07 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -76.07 171.78 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.375 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.1 174.1 6.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.44 133.92 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.69 65.75 1.4 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -108.48 37.09 2.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -117.28 30.84 7.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.287 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 mt -150.05 49.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.033 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.32 -59.46 3.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.25 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -107.75 162.45 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.563 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' CE2' ' HG2' ' A' ' 9' ' ' PRO . 48.8 t80 -106.31 146.58 30.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.29 134.91 17.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.003 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 m -89.85 125.89 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.1 mm -89.53 121.23 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 21.2 p -132.55 -162.68 1.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.015 0.436 . . . . 0.0 111.875 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.53 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.71 134.87 31.41 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.001 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 6.2 Cg_endo -48.17 85.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.0 112.342 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 165.5 -29.63 0.21 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.24 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -89.89 104.98 17.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.92 -168.36 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.3 -164.03 12.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 m -92.05 -31.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -122.5 24.38 9.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.44 90.15 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.212 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 33.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.756 179.789 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -35.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -135.55 8.16 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.87 101.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.574 0.226 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 66.3 Cg_endo -72.74 -5.85 17.94 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.485 2.124 . . . . 0.0 112.759 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.7 m -56.23 -171.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 -58.74 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.991 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -89.65 -145.47 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.454 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.56 54.77 3.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.046 0.451 . . . . 0.0 110.636 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.27 172.2 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.211 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.65 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.17 152.68 19.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 tp -163.31 78.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 25.4 t0 -112.55 136.17 52.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -97.57 -69.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.1 pt -140.28 -42.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.392 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.83 -35.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.923 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -89.78 121.16 31.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 7.1 t80 -100.24 147.19 26.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.765 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.413 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 tt0 -145.88 141.24 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 m -115.54 134.25 55.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.73 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 26' ' ' ILE . 29.3 mm -89.77 121.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 p -130.03 -166.7 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.382 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.532 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -89.64 135.45 30.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.844 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.532 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 4.6 Cg_exo -38.96 121.65 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.044 2.496 . . . . 0.0 112.386 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.31 -16.42 27.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.233 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -89.84 88.85 7.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 110.492 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.9 -179.61 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.268 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 38' ' ' ILE . . . 122.68 -158.06 17.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.534 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.91 -32.57 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -135.66 28.17 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.676 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.83 86.31 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.11 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 ' CD1' ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.556 0.217 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.05 -32.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 111.252 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -115.39 -13.68 11.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.632 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 63.4 97.88 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.659 0.266 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.3 Cg_endo -69.68 -12.93 34.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.575 2.183 . . . . 0.0 112.775 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.9 m -57.64 -169.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.802 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -54.84 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -89.77 -141.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.491 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.0 38.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 111.18 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.01 169.97 17.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.45 169.63 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 p -102.56 136.49 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.69 87.06 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -113.28 164.53 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.55 -65.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.44 -54.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 26.82 1.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.52 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.56 88.82 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 44.5 t80 -90.27 145.38 25.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.06 152.37 34.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 m -113.99 129.98 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.76 121.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 p -128.75 -167.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.393 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.433 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 8.5 mmm -89.78 130.43 42.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.223 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.8 Cg_exo -38.81 98.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 112.285 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.31 -11.55 3.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.398 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -89.72 104.34 16.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -178.42 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.96 -172.37 15.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.82 -30.49 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -124.83 28.29 6.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m 60.26 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -158.72 37.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.828 0.347 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.41 -36.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -122.51 -2.79 8.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.503 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 60.12 103.48 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 110.743 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 46.3 Cg_endo -68.75 -9.27 25.72 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.342 2.028 . . . . 0.0 112.828 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.01 -165.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.517 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.64 -43.32 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -89.64 -86.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.128 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -150.13 27.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -76.3 155.94 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.268 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 178.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -105.96 142.75 35.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.67 87.85 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 7.3 t70 -125.96 78.93 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -150.26 25.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.11 35.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.43 10.04 59.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.646 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.19 151.39 32.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.722 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 5.3 t80 -117.77 133.94 55.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.75 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -150.18 139.42 21.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 m -89.88 133.9 34.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 mm -92.74 120.84 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.721 0.296 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 8.3 p -115.65 -166.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.376 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.421 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -89.82 148.47 39.91 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 10.3 Cg_endo -50.79 93.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.804 2.336 . . . . 0.0 111.864 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.42 -8.52 5.32 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -89.82 121.66 32.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.682 0.277 . . . . 0.0 110.428 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -107.64 -165.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.33 -166.64 12.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.473 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.8 -43.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.819 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.12 32.52 5.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.018 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER 56.64 80.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -159.46 44.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.462 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.093 179.744 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 98.3 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.842 0.353 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.3 -32.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -122.62 12.94 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.346 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.05 109.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.608 0.242 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 56.8 Cg_endo -69.88 -9.58 26.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.367 2.044 . . . . 0.0 112.529 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.87 -166.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.93 -41.58 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.322 . . . . 0.0 111.496 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.8 -88.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.052 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.19 29.79 0.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.6 156.49 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -89.94 167.04 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -103.64 136.69 42.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -133.0 80.28 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 8.6 t0 -93.15 138.92 31.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -124.17 -73.97 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.67 69.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.8 -44.37 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.0 158.01 16.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 26.9 p90 -155.38 -179.47 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -148.07 142.01 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.832 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.26 125.65 36.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 26' ' ' ILE . 33.0 mm -89.87 122.53 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.657 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 p -124.32 -164.72 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.492 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.6 136.73 29.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.51 97.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.116 2.544 . . . . 0.0 112.457 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.65 -13.98 4.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.236 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.78 106.24 18.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.1 179.67 4.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.41 -160.77 19.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.374 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 m -89.96 -32.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.352 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.58 29.45 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.753 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.37 82.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -172.15 32.94 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.831 0.348 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.57 -30.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -139.84 22.58 2.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 60.87 115.17 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 84.7 Cg_endo -75.69 -14.17 19.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.196 . . . . 0.0 112.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -50.59 174.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -110.22 -44.41 3.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.348 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -89.98 -90.33 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.076 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -150.29 33.28 0.65 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.81 158.89 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.326 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -93.92 152.43 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.81 138.2 31.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.16 90.08 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 10.8 p30 -89.79 147.68 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -129.49 -75.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.22 66.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.22 -27.37 17.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.469 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -122.79 147.03 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 5.4 p90 -134.58 -175.41 3.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 138.0 20.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 m -89.79 126.62 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.629 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.79 121.28 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.14 -165.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.177 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.482 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.63 135.6 30.55 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.8 Cg_endo -41.28 103.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.101 2.534 . . . . 0.0 112.617 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.07 -11.0 5.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.494 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.85 95.49 10.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.733 0.301 . . . . 0.0 110.642 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.52 -167.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.7 -155.31 17.3 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.434 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.85 -32.09 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.746 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 13.9 m-85 -135.6 50.0 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.29 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.8 p 43.76 51.78 6.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.602 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -122.35 37.22 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.029 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.655 0.264 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.07 -36.59 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.3 m -105.78 -7.96 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.285 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 62.03 91.45 0.08 OUTLIER Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.069 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 37.0 Cg_endo -65.64 -19.21 59.97 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.53 2.154 . . . . 0.0 112.248 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.45 -169.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -59.18 2.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -89.86 -146.42 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.39 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.85 48.41 1.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.99 176.6 9.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -117.06 143.0 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 31.7 p -89.93 134.76 34.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 86.27 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.92 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -118.75 156.86 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 tt -135.5 -45.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.286 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.26 36.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.618 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -149.82 117.15 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 22.8 t80 -120.89 136.6 54.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -150.06 132.05 15.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 m -90.78 123.09 34.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -89.82 122.64 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.61 -167.84 1.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.578 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.465 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 13.1 mmm -89.7 130.9 41.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.306 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.9 Cg_exo -38.13 92.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.286 2.657 . . . . 0.0 112.363 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.45 -17.5 1.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.364 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 66.4 m-85 -89.72 109.12 20.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.12 -176.23 3.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.11 -160.25 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.418 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.83 -32.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 110.732 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 1.8 m-85 -129.5 30.9 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.629 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.1 m 61.19 81.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -160.52 39.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.108 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.811 0.339 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 t -80.85 149.89 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -155.9 -46.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -31.14 14.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 m -97.41 40.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.17 -27.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 p -110.97 -23.0 11.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.29 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 51.1 Cg_exo -55.13 -20.15 23.11 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.665 2.243 . . . . 0.0 112.569 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -48.71 171.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.624 0.249 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -39.01 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 111.682 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -89.9 -89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -150.19 35.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 110.982 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.2 160.89 20.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -176.08 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.56 153.6 19.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -161.23 89.67 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 5.4 t0 -139.72 138.85 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.29 -59.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -143.34 -45.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.64 39.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.591 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -149.99 79.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.792 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 3.8 t80 -89.53 130.86 35.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -150.22 139.0 20.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 m -89.77 133.09 34.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.85 122.38 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 25.8 p -129.67 -164.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.572 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.42 ' HE3' ' HD2' ' A' ' 29' ' ' PRO . 3.7 tpt -89.7 140.44 28.02 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.502 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' HE3' ' A' ' 28' ' ' MET . 9.2 Cg_endo -50.53 89.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.098 2.532 . . . . 0.0 111.828 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.86 -20.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -89.63 122.63 32.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 110.366 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -102.46 -174.85 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.87 -173.84 15.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.85 -30.59 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.42 25.74 8.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.8 OUTLIER 60.41 90.16 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -177.0 42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.288 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.847 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.13 139.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.044 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -59.78 174.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' OE2' ' CE2' ' A' ' 23' ' ' PHE . 4.8 mm-40 -129.72 31.51 4.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.978 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.94 19.31 1.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 tt -114.33 21.38 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.302 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 m -150.1 -42.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.155 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.4 88.97 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.745 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 59.4 Cg_endo -71.92 -5.67 17.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.746 2.297 . . . . 0.0 112.9 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.1 m -56.71 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.26 -43.61 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 -91.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.061 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.12 31.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -70.53 165.45 22.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.497 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.42 171.13 8.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.74 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 p -92.24 153.84 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.111 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -158.02 77.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.7 t70 -126.57 142.11 51.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -150.07 -71.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.53 38.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 11.96 61.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.71 70.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.658 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 2.0 t80 -76.91 129.52 36.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.191 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.32 136.03 18.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.6 m -93.1 139.99 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.342 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.3 mm -99.05 121.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -124.06 -170.72 2.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.208 0.528 . . . . 0.0 112.099 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.458 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 1.6 mtp -89.65 160.49 41.44 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.424 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.458 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 9.8 Cg_endo -50.07 125.0 13.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.928 2.419 . . . . 0.0 111.668 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.19 -5.67 63.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.405 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.79 104.59 17.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.73 0.3 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.73 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.342 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.09 -169.86 13.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.431 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -89.65 -29.91 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.768 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -126.61 29.06 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.712 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.4 m 60.98 91.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.565 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -177.36 42.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.056 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.7 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.103 179.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.868 0.366 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.85 103.18 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -94.0 11.1 30.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.276 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.92 -44.24 6.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 85.5 m -100.79 29.86 4.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.908 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 tt -92.41 -30.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.8 t -116.18 17.36 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.32 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 53.94 97.55 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 65.4 Cg_endo -72.43 -16.77 27.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.506 2.138 . . . . 0.0 112.506 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.3 m -56.55 -169.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -57.65 2.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.76 -145.88 0.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.76 53.34 2.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.95 -178.96 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.234 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -124.89 140.29 53.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -89.96 145.32 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 tp -141.41 87.8 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.013 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.67 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 14.7 t70 -90.01 150.5 22.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -126.92 -60.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.645 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.95 -63.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.837 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.17 4.52 5.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.805 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -150.22 162.33 40.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 33.1 p90 -148.82 -177.1 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.8 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 138.77 29.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.765 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -93.75 123.68 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.075 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.81 122.62 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.547 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -129.1 -165.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 8.0 mmm -89.84 128.16 51.27 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 2.0 Cg_endo -40.82 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.945 2.43 . . . . 0.0 112.267 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.04 -18.79 1.76 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.375 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.74 96.39 10.67 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.77 0.319 . . . . 0.0 110.421 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -174.89 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.47 -159.36 14.75 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.261 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 m -89.87 -36.24 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.52 30.57 5.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.577 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 62.66 76.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -150.9 41.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.86 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.906 0.384 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 t -97.46 84.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -107.9 -47.25 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.06 -32.13 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -95.77 35.34 1.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 tp -95.56 -32.2 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -144.76 15.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.389 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.98 112.31 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 69.6 Cg_endo -73.58 -18.05 22.9 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.431 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m -63.04 -175.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.39 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -55.52 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -89.33 -168.43 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.81 52.49 2.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.05 176.73 4.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -89.96 165.28 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.32 123.15 37.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.968 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.86 87.19 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 31.7 t70 -135.81 161.24 36.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.41 -65.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.08 -46.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.77 -33.85 0.78 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.725 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.88 106.66 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.99 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 9.7 t80 -113.06 121.51 44.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.09 141.18 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.972 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.32 155.68 18.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.8 120.59 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.046 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 p -120.98 -170.63 2.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.562 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.436 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 8.3 mmm -89.86 129.95 44.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.114 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 4.5 Cg_exo -38.81 91.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.176 2.584 . . . . 0.0 112.371 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 150.34 -24.14 1.09 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.107 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 17.1 m-30 -89.84 83.86 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.469 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -90.06 -177.1 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.11 -154.86 16.28 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.565 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.91 -30.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 1.1 m-85 -131.24 31.36 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m 54.47 74.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.93 30.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.149 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.8 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.739 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.14 91.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -79.26 80.19 5.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.06 -71.55 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 m -122.49 29.21 7.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -103.45 -33.1 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -117.76 -13.32 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.454 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.62 97.36 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.61 0.243 . . . . 0.0 110.82 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -66.35 -12.95 37.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.487 2.125 . . . . 0.0 112.638 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -55.85 175.76 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.757 0.313 . . . . 0.0 110.783 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -59.44 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.76 -145.4 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.418 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.76 50.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.939 0.399 . . . . 0.0 110.827 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.26 158.62 16.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.07 163.07 15.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 p -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tt -142.65 96.54 2.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 27.7 t0 -128.06 131.79 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.51 -74.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.96 73.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.35 -29.51 11.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.96 134.71 34.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.1 t80 -134.92 141.13 46.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.975 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -150.08 131.45 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.86 129.87 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.83 121.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.486 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 p -126.93 -167.03 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.414 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.445 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 10.1 tpt -89.71 120.43 69.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.34 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 83.9 Cg_exo -33.55 95.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.223 2.615 . . . . 0.0 112.725 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.61 -12.83 2.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.52 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 28' ' ' MET . 38.9 m-85 -89.72 107.37 19.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.828 0.346 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -175.31 4.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.361 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.5 -166.63 12.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.41 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.82 -32.37 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.669 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -128.23 29.08 5.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.537 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.4 m 61.09 76.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -141.1 28.77 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.4 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.64 124.54 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.91 -171.36 2.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.33 -31.1 11.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.9 m -96.1 61.76 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.66 -40.29 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -138.79 18.61 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 57.08 104.37 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.1 Cg_endo -70.08 -19.22 34.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.474 2.116 . . . . 0.0 112.342 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 m -54.64 -178.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.77 -58.43 1.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.07 0.462 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -89.81 -144.94 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.508 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.81 51.94 2.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.42 147.59 24.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -90.39 157.8 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 26.5 p -91.61 151.11 20.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 87.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 17.6 t0 -127.52 150.25 49.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -132.98 -54.3 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pp -149.42 -46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.82 34.75 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.529 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -150.01 108.99 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.3 t80 -114.68 135.43 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.99 130.38 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.0 m -90.45 130.25 36.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.88 123.33 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.446 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.27 -169.72 2.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.437 . . . . 0.0 111.629 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.447 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 9.0 mmm -89.97 129.41 46.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 2.9 Cg_endo -39.63 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.2 2.6 . . . . 0.0 112.421 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 152.99 -25.7 0.81 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.25 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.1 m-30 -89.79 111.91 23.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.666 0.269 . . . . 0.0 110.463 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -110.6 -175.97 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.149 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.06 -151.4 17.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.91 -31.95 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 110.922 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.7 m-85 -133.77 28.85 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.725 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.65 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.634 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -171.0 40.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.001 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.038 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.12 132.84 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -170.57 150.14 3.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 31.23 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.1 23.53 13.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.51 HG22 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.11 -35.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.148 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -106.77 -20.1 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 62.76 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 44.7 Cg_endo -68.3 -9.74 26.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.84 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.8 m -58.85 -163.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.08 -45.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -90.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -150.12 29.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 110.67 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -70.1 162.34 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 171.41 9.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.88 124.59 49.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.89 89.14 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -113.48 168.58 9.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -150.08 -65.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.715 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -150.16 -45.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.83 -33.52 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.891 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -89.77 152.3 21.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.057 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 11.5 t80 -155.79 139.35 15.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.19 138.87 20.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.0 m -89.94 141.04 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 27.6 mm -99.51 122.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 5.2 p -119.06 -171.44 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.687 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.438 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 12.0 mmm -89.8 132.1 37.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 5.7 Cg_exo -36.49 92.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.383 2.722 . . . . 0.0 112.454 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.26 -23.28 1.56 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.184 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -89.8 122.88 33.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 110.418 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -164.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.113 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.38 -171.79 14.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.436 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.91 -32.86 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.48 24.19 11.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.33 81.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.645 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.18 49.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.283 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.179 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.97 136.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -151.41 -58.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.97 28.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 54.2 m -111.14 22.98 14.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.93 -31.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.24 -21.83 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 66.11 105.88 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 80.2 Cg_endo -75.47 -25.33 11.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.604 2.203 . . . . 0.0 112.179 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.2 m -51.35 165.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.02 -56.44 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.107 0.479 . . . . 0.0 111.101 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -89.68 -143.39 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.74 59.65 4.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.91 151.32 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.975 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -95.89 167.1 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 p -95.43 157.52 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.801 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -149.12 87.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -120.93 138.63 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -122.91 -78.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -150.06 30.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.235 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.68 -37.91 0.54 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.584 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.92 133.63 34.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 110.977 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.536 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 2.0 t80 -135.94 124.43 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -150.15 141.23 23.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 135.41 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.725 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mm -96.25 123.08 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 7.3 p -126.99 -165.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.524 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.64 136.56 29.41 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.328 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.96 103.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.97 2.447 . . . . 0.0 112.374 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.13 -20.94 3.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.128 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.89 112.69 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.278 . . . . 0.0 110.252 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.29 -165.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -168.54 12.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.263 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 m -89.88 -29.97 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.6 m-85 -125.23 27.85 6.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 61.21 86.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.732 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.54 41.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.6 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.213 -179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.812 0.339 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.43 86.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -118.09 33.24 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 -38.45 11.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.1 m -98.05 30.05 3.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.45 -31.16 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.51 -27.76 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 63.57 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 58.4 Cg_endo -70.47 -14.1 33.5 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 m -56.49 -173.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.741 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -106.55 -60.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -89.75 -147.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.5 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.68 59.56 4.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.042 0.448 . . . . 0.0 110.684 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.85 177.18 6.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.131 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 177.68 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.3 t -102.57 149.4 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 72.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -108.26 145.32 34.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -122.65 -72.26 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.3 -66.72 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.99 -27.83 3.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.589 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.94 159.01 17.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 53.1 t80 -146.35 145.88 30.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -144.44 157.92 44.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.93 127.87 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.9 mm -89.87 122.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.442 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.3 p -128.04 -168.18 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.581 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.454 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 9.7 mmm -89.83 129.88 44.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.5 Cg_exo -38.94 91.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.198 2.599 . . . . 0.0 112.383 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.29 -26.3 0.98 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.134 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.2 m-30 -89.85 117.86 29.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.327 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -118.08 -175.62 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 111.203 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.44 -152.52 16.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.86 -31.27 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -132.26 28.97 4.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.52 90.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -170.86 35.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.054 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.19 112.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -89.19 95.09 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -100.41 -32.86 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 62.8 m -98.18 29.09 3.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -97.97 -34.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -101.91 -29.94 11.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 62.51 115.75 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 68.5 Cg_endo -82.44 1.54 9.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.699 2.266 . . . . 0.0 112.316 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 m -60.13 -165.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.773 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -45.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -89.98 -88.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -150.27 30.19 0.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.763 0.315 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 168.41 17.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.21 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 -165.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.23 146.2 51.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.863 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -160.71 100.66 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' HA ' ' CB ' ' A' ' 23' ' ' PHE . 4.8 p-10 -92.48 176.01 6.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -147.22 -62.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 pt -149.69 77.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.07 -48.05 2.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.37 163.14 13.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 110.819 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.614 ' CB ' ' HA ' ' A' ' 18' ' ' ASP . 1.8 p90 -155.78 -179.64 8.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -147.68 155.03 41.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 m -89.39 141.65 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.825 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 26' ' ' ILE . 1.3 mp -101.49 128.4 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.533 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.8 p -118.49 -171.6 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.152 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.427 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 3.0 tpt -89.61 137.12 28.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.9 Cg_exo -36.98 104.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.172 2.581 . . . . 0.0 112.753 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.87 -9.76 7.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.512 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.89 111.95 23.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.03 -168.15 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.75 176.07 21.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.447 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.02 -29.85 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.307 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.5 m-85 -117.68 24.92 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 57.74 82.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.96 42.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.4 mm . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.159 179.885 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.03 127.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -106.96 139.88 40.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -96.37 -27.46 14.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.023 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.3 m -97.07 36.4 1.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -97.82 -33.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -5.35 11.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.325 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.04 118.92 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.82 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.2 Cg_endo -75.92 -22.06 13.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.533 2.156 . . . . 0.0 112.408 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.1 m -58.84 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.15 -43.43 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.401 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.88 -88.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.082 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -150.24 27.28 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.91 156.92 38.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.5 m -90.0 145.29 25.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 p -90.24 135.37 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tp -127.36 79.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.2 t0 -95.97 157.97 15.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.07 -49.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -150.0 57.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.82 -48.76 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.83 159.3 16.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.669 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.0 p90 -164.25 -178.1 5.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -146.95 136.88 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.0 129.83 37.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.811 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mm -98.86 124.59 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.738 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 4.2 p -118.47 -176.24 3.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.407 ' HE1' ' CD ' ' A' ' 29' ' ' PRO . 10.8 mmm -89.76 136.91 28.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' HE1' ' A' ' 28' ' ' MET . 14.6 Cg_exo -31.01 122.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.755 2.97 . . . . 0.0 112.77 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.02 -10.02 51.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.331 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.85 108.85 19.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.716 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -166.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.51 -176.85 18.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.545 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.01 -35.04 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.14 25.36 10.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.068 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.6 OUTLIER 59.54 78.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.47 42.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 179.843 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.0 t -69.15 126.31 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -97.4 42.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 3.6 tp10 -98.94 -37.99 9.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -100.97 27.68 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -108.57 -33.79 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 -17.0 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.274 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.86 100.01 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 49.8 Cg_endo -68.68 -9.52 26.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.51 2.14 . . . . 0.0 112.738 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.4 m -48.92 170.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.807 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -102.43 -48.04 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -90.04 -91.86 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.28 36.37 0.67 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.22 172.3 10.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.88 178.61 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 t -95.78 155.83 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.69 79.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.41 158.62 22.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -144.42 -82.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -146.85 83.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.67 -35.59 4.33 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.94 157.31 16.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 13.3 t80 -158.63 144.38 16.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 5.6 mt-30 -150.05 149.8 30.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.16 127.82 54.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.777 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 mm -89.73 122.2 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -128.38 -158.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.421 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.463 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 8.1 tpt -89.62 133.13 34.96 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.381 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.5 Cg_exo -30.26 115.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.659 2.906 . . . . 0.0 113.003 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.2 23.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.21 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 27.6 m-85 -89.82 75.92 7.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.566 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.92 -175.73 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.41 -115.66 3.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.36 -45.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 111.411 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -127.69 31.93 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.1 t 59.41 85.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.876 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.32 34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.132 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.8 mp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.61 125.96 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.193 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 59.58 28.84 18.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -143.16 -48.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.806 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.6 m -103.73 29.37 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -94.73 -32.05 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.1 p -136.12 12.6 3.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.306 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.18 118.15 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.9 Cg_endo -74.77 -16.7 20.68 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.466 2.111 . . . . 0.0 112.364 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -57.91 -166.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 -42.01 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.571 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -89.95 -88.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.208 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.12 43.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.978 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.84 158.28 15.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.9 158.36 15.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.714 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.03 148.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.35 74.33 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.7 t0 -95.34 131.12 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -125.4 -68.26 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.59 72.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -54.8 4.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -90.02 162.2 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 46.3 p90 -157.73 179.83 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 141.01 22.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.84 133.9 34.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.14 123.07 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.9 p -119.75 -168.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 9.4 mmm -89.58 131.88 38.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 2.9 Cg_exo -34.93 97.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.432 2.754 . . . . 0.0 112.645 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.92 -13.3 4.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.374 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.85 106.94 18.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.98 -168.23 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.82 -175.95 16.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.0 -29.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -128.7 30.55 5.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.2 m 60.79 91.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -169.73 33.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 0.0 111.088 179.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.38 65.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -124.74 129.68 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -109.71 -29.49 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.968 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.5 m -97.84 30.02 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.99 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -101.29 -31.95 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -104.93 -30.78 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.83 91.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 23' ' ' PHE . 69.6 Cg_exo -51.59 -22.25 12.46 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.535 2.157 . . . . 0.0 112.578 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.9 m -45.95 164.26 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.685 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.91 -40.57 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -89.83 -94.14 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -150.24 41.07 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -76.07 171.78 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.375 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.1 174.1 6.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.44 133.92 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.014 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.69 65.75 1.4 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -108.48 37.09 2.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -117.28 30.84 7.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.287 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.3 mt -150.05 49.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.033 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.32 -59.46 3.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.25 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -107.75 162.45 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.563 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' CE2' ' HG2' ' A' ' 9' ' ' PRO . 48.8 t80 -106.31 146.58 30.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.29 134.91 17.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.003 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 m -89.85 125.89 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.1 mm -89.53 121.23 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 21.2 p -132.55 -162.68 1.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.015 0.436 . . . . 0.0 111.875 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.53 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.71 134.87 31.41 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.001 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 6.2 Cg_endo -48.17 85.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.0 112.342 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 165.5 -29.63 0.21 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.24 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -89.89 104.98 17.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.92 -168.36 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.3 -164.03 12.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 m -92.05 -31.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -122.5 24.38 9.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.44 90.15 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.212 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 33.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.756 179.789 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -97.74 35.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 59.2 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 -56.81 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.01 29.75 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -35.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -135.55 8.16 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.87 101.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.574 0.226 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 66.3 Cg_endo -72.74 -5.85 17.94 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.485 2.124 . . . . 0.0 112.759 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.7 m -56.23 -171.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.52 -58.74 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.991 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -89.65 -145.47 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.454 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.56 54.77 3.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.046 0.451 . . . . 0.0 110.636 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.27 172.2 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.211 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.65 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -100.17 152.68 19.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 tp -163.31 78.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 25.4 t0 -112.55 136.17 52.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -97.57 -69.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.1 pt -140.28 -42.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.392 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.83 -35.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.923 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -89.78 121.16 31.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 7.1 t80 -100.24 147.19 26.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.765 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.413 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 tt0 -145.88 141.24 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 m -115.54 134.25 55.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.73 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 26' ' ' ILE . 29.3 mm -89.77 121.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 p -130.03 -166.7 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.382 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.532 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -89.64 135.45 30.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.844 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.532 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 4.6 Cg_exo -38.96 121.65 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.044 2.496 . . . . 0.0 112.386 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.31 -16.42 27.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.233 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -89.84 88.85 7.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 110.492 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.9 -179.61 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.268 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 38' ' ' ILE . . . 122.68 -158.06 17.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.534 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.91 -32.57 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -135.66 28.17 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.676 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.83 86.31 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.11 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 ' CD1' ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.45 133.91 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.02 167.2 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -113.89 -32.04 6.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.79 15.56 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.05 -32.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 111.252 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -115.39 -13.68 11.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.632 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 63.4 97.88 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.659 0.266 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.3 Cg_endo -69.68 -12.93 34.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.575 2.183 . . . . 0.0 112.775 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.9 m -57.64 -169.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.802 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -54.84 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -89.77 -141.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.491 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.0 38.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 111.18 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.01 169.97 17.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.45 169.63 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 p -102.56 136.49 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.69 87.06 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -113.28 164.53 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.55 -65.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.871 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.44 -54.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 26.82 1.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.52 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.56 88.82 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 44.5 t80 -90.27 145.38 25.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.06 152.37 34.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 m -113.99 129.98 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.76 121.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 p -128.75 -167.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.393 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.433 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 8.5 mmm -89.78 130.43 42.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.223 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.8 Cg_exo -38.81 98.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 112.285 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.31 -11.55 3.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.398 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -89.72 104.34 16.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -178.42 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.96 -172.37 15.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.82 -30.49 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -124.83 28.29 6.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m 60.26 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -158.72 37.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.0 t0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.44 82.57 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -171.51 80.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.6 -62.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.1 m -121.78 25.57 9.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.04 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.41 -36.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -122.51 -2.79 8.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.503 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 60.12 103.48 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 110.743 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 46.3 Cg_endo -68.75 -9.27 25.72 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.342 2.028 . . . . 0.0 112.828 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.01 -165.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.517 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.64 -43.32 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -89.64 -86.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.128 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -150.13 27.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 26' ' ' ILE . . . -76.3 155.94 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.268 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.96 178.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -105.96 142.75 35.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.67 87.85 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 7.3 t70 -125.96 78.93 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -150.26 25.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.11 35.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.43 10.04 59.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.646 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.19 151.39 32.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.722 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 5.3 t80 -117.77 133.94 55.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.75 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -150.18 139.42 21.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 m -89.88 133.9 34.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 mm -92.74 120.84 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.721 0.296 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 8.3 p -115.65 -166.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.376 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.421 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -89.82 148.47 39.91 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 10.3 Cg_endo -50.79 93.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.804 2.336 . . . . 0.0 111.864 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.42 -8.52 5.32 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -89.82 121.66 32.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.682 0.277 . . . . 0.0 110.428 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -107.64 -165.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.33 -166.64 12.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.473 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.8 -43.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.819 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.12 32.52 5.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.018 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER 56.64 80.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -159.46 44.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.462 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.093 179.744 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.14 87.38 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.074 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.55 -174.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.93 -61.58 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 98.3 m -96.49 40.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.3 -32.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -122.62 12.94 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.346 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.05 109.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.608 0.242 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 56.8 Cg_endo -69.88 -9.58 26.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.367 2.044 . . . . 0.0 112.529 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.4 m -57.87 -166.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.93 -41.58 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.322 . . . . 0.0 111.496 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.8 -88.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.052 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.19 29.79 0.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.6 156.49 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -89.94 167.04 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -103.64 136.69 42.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -133.0 80.28 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 8.6 t0 -93.15 138.92 31.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -124.17 -73.97 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.67 69.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.8 -44.37 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.0 158.01 16.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 26.9 p90 -155.38 -179.47 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -148.07 142.01 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.832 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.26 125.65 36.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 26' ' ' ILE . 33.0 mm -89.87 122.53 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.657 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 p -124.32 -164.72 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.492 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.6 136.73 29.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.51 97.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.116 2.544 . . . . 0.0 112.457 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.65 -13.98 4.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.236 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.78 106.24 18.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.1 179.67 4.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.41 -160.77 19.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.374 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 m -89.96 -32.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.352 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.58 29.45 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.753 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.37 82.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -172.15 32.94 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.31 137.2 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.36 -173.06 2.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.38 -48.42 5.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 m -113.74 82.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.57 -30.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -139.84 22.58 2.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 60.87 115.17 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 84.7 Cg_endo -75.69 -14.17 19.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.196 . . . . 0.0 112.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -50.59 174.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -110.22 -44.41 3.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.348 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -89.98 -90.33 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.076 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -150.29 33.28 0.65 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.81 158.89 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.326 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -93.92 152.43 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.81 138.2 31.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.16 90.08 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 10.8 p30 -89.79 147.68 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -129.49 -75.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.22 66.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.22 -27.37 17.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.469 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -122.79 147.03 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 5.4 p90 -134.58 -175.41 3.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 138.0 20.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 m -89.79 126.62 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.629 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.79 121.28 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.14 -165.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.177 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.482 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.63 135.6 30.55 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.8 Cg_endo -41.28 103.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.101 2.534 . . . . 0.0 112.617 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.07 -11.0 5.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.494 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.85 95.49 10.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.733 0.301 . . . . 0.0 110.642 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.52 -167.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.7 -155.31 17.3 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.434 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.85 -32.09 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.746 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 13.9 m-85 -135.6 50.0 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.29 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.8 p 43.76 51.78 6.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.602 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -122.35 37.22 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.029 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.853 0.359 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.2 t -93.8 98.21 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.09 -168.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.9 -55.07 3.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.54 23.78 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.07 -36.59 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.3 m -105.78 -7.96 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.285 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 62.03 91.45 0.08 OUTLIER Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.069 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 37.0 Cg_endo -65.64 -19.21 59.97 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.53 2.154 . . . . 0.0 112.248 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.45 -169.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -59.18 2.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -89.86 -146.42 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.39 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.85 48.41 1.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.99 176.6 9.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -117.06 143.0 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 31.7 p -89.93 134.76 34.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 86.27 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.92 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -118.75 156.86 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 tt -135.5 -45.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.286 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.26 36.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.618 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -149.82 117.15 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 22.8 t80 -120.89 136.6 54.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -150.06 132.05 15.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 m -90.78 123.09 34.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -89.82 122.64 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.61 -167.84 1.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.578 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.465 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 13.1 mmm -89.7 130.9 41.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.306 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.9 Cg_exo -38.13 92.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.286 2.657 . . . . 0.0 112.363 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.45 -17.5 1.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.364 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 66.4 m-85 -89.72 109.12 20.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.12 -176.23 3.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.11 -160.25 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.418 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.83 -32.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 110.732 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 1.8 m-85 -129.5 30.9 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.629 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.1 m 61.19 81.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -160.52 39.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.108 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.845 0.355 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.17 -27.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 p -110.97 -23.0 11.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.29 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 51.1 Cg_exo -55.13 -20.15 23.11 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.665 2.243 . . . . 0.0 112.569 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -48.71 171.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.624 0.249 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -39.01 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 111.682 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -89.9 -89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -150.19 35.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 110.982 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -84.2 160.89 20.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -176.08 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.56 153.6 19.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 26' ' ' ILE . 3.1 tt -161.23 89.67 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 5.4 t0 -139.72 138.85 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.29 -59.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -143.34 -45.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -151.64 39.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.591 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -149.99 79.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.792 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 3.8 t80 -89.53 130.86 35.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -150.22 139.0 20.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 m -89.77 133.09 34.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 31.9 mm -89.85 122.38 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 25.8 p -129.67 -164.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.572 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' HG2' ' A' ' 29' ' ' PRO . 3.7 tpt -89.7 140.44 28.02 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.502 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HG2' ' HE2' ' A' ' 28' ' ' MET . 9.2 Cg_endo -50.53 89.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.098 2.532 . . . . 0.0 111.828 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.86 -20.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -89.63 122.63 32.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 110.366 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -102.46 -174.85 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.87 -173.84 15.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.85 -30.59 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.42 25.74 8.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.8 OUTLIER 60.41 90.16 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.746 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -177.0 42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.746 HD13 ' O ' ' A' ' 37' ' ' GLU . 13.8 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.653 0.263 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 tt -114.33 21.38 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.302 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 m -150.1 -42.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.155 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.4 88.97 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.745 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 59.4 Cg_endo -71.92 -5.67 17.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.746 2.297 . . . . 0.0 112.9 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.1 m -56.71 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -125.26 -43.61 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 -91.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.061 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.12 31.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.53 165.45 22.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.497 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.42 171.13 8.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.74 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 p -92.24 153.84 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.111 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -158.02 77.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.7 t70 -126.57 142.11 51.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -150.07 -71.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.53 38.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 11.96 61.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.71 70.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.658 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 2.0 t80 -76.91 129.52 36.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.191 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.32 136.03 18.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.6 m -93.1 139.99 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.342 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.3 mm -99.05 121.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -124.06 -170.72 2.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.208 0.528 . . . . 0.0 112.099 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.457 ' HE3' ' HD2' ' A' ' 29' ' ' PRO . 1.6 mtp -89.65 160.49 41.44 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.424 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' ' HE3' ' A' ' 28' ' ' MET . 9.8 Cg_endo -50.07 125.0 13.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.928 2.419 . . . . 0.0 111.668 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.19 -5.67 63.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.405 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.79 104.59 17.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.73 0.3 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.73 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.342 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.09 -169.86 13.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.431 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -89.65 -29.91 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.768 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -126.61 29.06 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.712 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.4 m 60.98 91.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.565 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.658 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.1 pp20? -177.36 42.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.056 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.7 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.103 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 85.5 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.859 0.361 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 tt -92.41 -30.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.8 t -116.18 17.36 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.32 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 53.94 97.55 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 65.4 Cg_endo -72.43 -16.77 27.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.506 2.138 . . . . 0.0 112.506 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 14.3 m -56.55 -169.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -57.65 2.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.76 -145.88 0.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.76 53.34 2.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -88.95 -178.96 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.234 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -124.89 140.29 53.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -89.96 145.32 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 tp -141.41 87.8 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.013 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 14.7 t70 -90.01 150.5 22.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 20' ' ' ILE . 16.8 mt-30 -126.92 -60.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.645 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -137.95 -63.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.837 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.17 4.52 5.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.805 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -150.22 162.33 40.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.69 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 33.1 p90 -148.82 -177.1 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.8 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -143.21 138.77 29.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.765 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -93.75 123.68 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.075 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.413 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.1 mm -89.81 122.62 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.547 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -129.1 -165.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.526 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.0 mmm -89.84 128.16 51.27 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.526 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.0 Cg_endo -40.82 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.945 2.43 . . . . 0.0 112.267 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.04 -18.79 1.76 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.375 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.74 96.39 10.67 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.77 0.319 . . . . 0.0 110.421 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -174.89 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.47 -159.36 14.75 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.261 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 m -89.87 -36.24 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.52 30.57 5.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.577 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 62.66 76.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.6 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -150.9 41.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.8 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.808 0.337 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 tp -95.56 -32.2 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -144.76 15.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.389 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.98 112.31 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 69.6 Cg_endo -73.58 -18.05 22.9 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.431 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m -63.04 -175.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.39 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -55.52 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -89.33 -168.43 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.81 52.49 2.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.05 176.73 4.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -89.96 165.28 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.32 123.15 37.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.968 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.69 HD12 HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -146.86 87.19 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 31.7 t70 -135.81 161.24 36.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.41 -65.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 21' ' ' GLY . 3.1 tt -150.08 -46.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.505 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -123.77 -33.85 0.78 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.725 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.88 106.66 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.99 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 9.7 t80 -113.06 121.51 44.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.09 141.18 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.972 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 1.7 m -105.32 155.68 18.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 17' ' ' LEU . 31.1 mm -89.8 120.59 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.046 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 p -120.98 -170.63 2.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.562 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.455 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 8.3 mmm -89.86 129.95 44.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.114 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 4.5 Cg_exo -38.81 91.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.176 2.584 . . . . 0.0 112.371 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 150.34 -24.14 1.09 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.107 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 17.1 m-30 -89.84 83.86 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.469 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -90.06 -177.1 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.845 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.11 -154.86 16.28 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.565 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.91 -30.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 1.1 m-85 -131.24 31.36 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m 54.47 74.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.837 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -166.93 30.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.149 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.845 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.8 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.739 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.79 0.329 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -103.45 -33.1 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -117.76 -13.32 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.454 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.62 97.36 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.61 0.243 . . . . 0.0 110.82 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -66.35 -12.95 37.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.487 2.125 . . . . 0.0 112.638 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 21.3 m -55.85 175.76 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.757 0.313 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -102.82 -59.44 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.76 -145.4 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.418 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.76 50.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.939 0.399 . . . . 0.0 110.827 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -91.26 158.62 16.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.07 163.07 15.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 p -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tt -142.65 96.54 2.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 27.7 t0 -128.06 131.79 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.51 -74.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.96 73.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.35 -29.51 11.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.96 134.71 34.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.1 t80 -134.92 141.13 46.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.975 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -150.08 131.45 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.86 129.87 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 25.7 mm -89.83 121.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 p -126.93 -167.03 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.414 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 10.1 tpt -89.71 120.43 69.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.34 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 83.9 Cg_exo -33.55 95.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.223 2.615 . . . . 0.0 112.725 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.61 -12.83 2.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.52 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 28' ' ' MET . 38.9 m-85 -89.72 107.37 19.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.828 0.346 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -175.31 4.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.361 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.5 -166.63 12.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.41 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.82 -32.37 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.669 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -128.23 29.08 5.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.537 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.4 m 61.09 76.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 11' ' ' GLN . 1.8 pp20? -141.1 28.77 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.4 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.941 0.4 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.66 -40.29 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -138.79 18.61 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 57.08 104.37 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.1 Cg_endo -70.08 -19.22 34.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.474 2.116 . . . . 0.0 112.342 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 14.1 m -54.64 -178.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.859 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -107.77 -58.43 1.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.07 0.462 . . . . 0.0 110.975 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -89.81 -144.94 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.508 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.81 51.94 2.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -97.42 147.59 24.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -90.39 157.8 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 26.5 p -91.61 151.11 20.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 87.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 17.6 t0 -127.52 150.25 49.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -132.98 -54.3 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 21' ' ' GLY . 2.1 pp -149.42 -46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.63 ' N ' HD12 ' A' ' 20' ' ' ILE . . . -150.82 34.75 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.529 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -150.01 108.99 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.3 t80 -114.68 135.43 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.99 130.38 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.0 m -90.45 130.25 36.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.88 123.33 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.446 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.27 -169.72 2.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.437 . . . . 0.0 111.629 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.466 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 9.0 mmm -89.97 129.41 46.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.9 Cg_endo -39.63 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.2 2.6 . . . . 0.0 112.421 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 152.99 -25.7 0.81 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.25 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.1 m-30 -89.79 111.91 23.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.666 0.269 . . . . 0.0 110.463 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -110.6 -175.97 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.149 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.06 -151.4 17.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.91 -31.95 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 110.922 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.7 m-85 -133.77 28.85 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.725 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.65 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.634 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.68 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.4 pp20? -171.0 40.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.001 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.3 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.719 0.295 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.11 -35.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.148 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -106.77 -20.1 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 62.76 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 44.7 Cg_endo -68.3 -9.74 26.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.84 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 15.8 m -58.85 -163.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.08 -45.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -90.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -150.12 29.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 110.67 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.1 162.34 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 171.41 9.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.88 124.59 49.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.89 89.14 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -113.48 168.58 9.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -150.08 -65.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.715 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -150.16 -45.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -133.83 -33.52 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.891 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -89.77 152.3 21.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.057 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 11.5 t80 -155.79 139.35 15.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.19 138.87 20.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.0 m -89.94 141.04 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 27.6 mm -99.51 122.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 5.2 p -119.06 -171.44 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.687 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 12.0 mmm -89.8 132.1 37.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 5.7 Cg_exo -36.49 92.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.383 2.722 . . . . 0.0 112.454 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.26 -23.28 1.56 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.184 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -89.8 122.88 33.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 110.418 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -164.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.113 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.38 -171.79 14.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.436 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.91 -32.86 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.48 24.19 11.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.33 81.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.645 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -175.18 49.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.283 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 37' ' ' GLU . 14.6 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.179 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 54.2 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.93 -31.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.24 -21.83 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 66.11 105.88 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 80.2 Cg_endo -75.47 -25.33 11.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.604 2.203 . . . . 0.0 112.179 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 6.2 m -51.35 165.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.759 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -101.02 -56.44 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.107 0.479 . . . . 0.0 111.101 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -89.68 -143.39 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.74 59.65 4.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -107.91 151.32 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -95.89 167.1 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 p -95.43 157.52 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.801 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -149.12 87.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -120.93 138.63 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -122.91 -78.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -150.06 30.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.235 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.68 -37.91 0.54 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.584 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.92 133.63 34.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 110.977 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 2.0 t80 -135.94 124.43 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -150.15 141.23 23.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 135.41 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.725 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.466 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.2 mm -96.25 123.08 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.595 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 7.3 p -126.99 -165.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.521 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.64 136.56 29.41 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.328 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.521 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.96 103.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.97 2.447 . . . . 0.0 112.374 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.13 -20.94 3.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.128 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.89 112.69 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.278 . . . . 0.0 110.252 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.29 -165.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -168.54 12.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.263 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 m -89.88 -29.97 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.6 m-85 -125.23 27.85 6.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 61.21 86.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.732 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -174.54 41.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 37' ' ' GLU . 15.6 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.213 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.45 -31.16 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.51 -27.76 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 63.57 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 58.4 Cg_endo -70.47 -14.1 33.5 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.0 m -56.49 -173.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.741 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 3.6 tm0? -106.55 -60.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -89.75 -147.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.5 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.68 59.56 4.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.042 0.448 . . . . 0.0 110.684 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -88.85 177.18 6.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.3 177.68 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.428 ' H ' HG22 ' A' ' 15' ' ' THR . 40.3 t -102.57 149.4 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 72.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -108.26 145.32 34.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -122.65 -72.26 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.3 -66.72 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.99 -27.83 3.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.589 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.94 159.01 17.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 53.1 t80 -146.35 145.88 30.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -144.44 157.92 44.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.93 127.87 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mm -89.87 122.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.442 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.3 p -128.04 -168.18 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.581 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 9.7 mmm -89.83 129.88 44.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 3.5 Cg_exo -38.94 91.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.198 2.599 . . . . 0.0 112.383 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.29 -26.3 0.98 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.134 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.2 m-30 -89.85 117.86 29.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.327 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -118.08 -175.62 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 111.203 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.44 -152.52 16.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.86 -31.27 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -132.26 28.97 4.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.52 90.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -170.86 35.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.4 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.054 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.756 0.312 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -97.97 -34.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -101.91 -29.94 11.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 62.51 115.75 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 68.5 Cg_endo -82.44 1.54 9.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.699 2.266 . . . . 0.0 112.316 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 m -60.13 -165.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.773 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -45.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -89.98 -88.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -150.27 30.19 0.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.763 0.315 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.52 168.41 17.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -101.08 -165.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' H ' HG22 ' A' ' 15' ' ' THR . 47.4 t -129.23 146.2 51.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -160.71 100.66 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.616 ' HA ' ' CB ' ' A' ' 23' ' ' PHE . 4.8 p-10 -92.48 176.01 6.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -147.22 -62.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 pt -149.69 77.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.07 -48.05 2.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.37 163.14 13.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 110.819 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 18' ' ' ASP . 1.8 p90 -155.78 -179.64 8.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -147.68 155.03 41.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' C ' HD12 ' A' ' 26' ' ' ILE . 18.8 m -89.39 141.65 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.825 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 26' ' ' ILE . 1.3 mp -101.49 128.4 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.533 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.8 p -118.49 -171.6 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.152 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.427 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 3.0 tpt -89.61 137.12 28.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.9 Cg_exo -36.98 104.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.172 2.581 . . . . 0.0 112.753 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.87 -9.76 7.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.512 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.89 111.95 23.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.03 -168.15 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.75 176.07 21.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.447 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.02 -29.85 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.307 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.5 m-85 -117.68 24.92 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 57.74 82.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.748 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -165.96 42.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 37' ' ' GLU . 16.4 mm . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.159 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.709 0.29 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -97.82 -33.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -5.35 11.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.325 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.04 118.92 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.82 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.2 Cg_endo -75.92 -22.06 13.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.533 2.156 . . . . 0.0 112.408 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.1 m -58.84 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.15 -43.43 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.401 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.88 -88.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.082 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -150.24 27.28 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -69.91 156.92 38.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.5 m -90.0 145.29 25.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 p -90.24 135.37 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tp -127.36 79.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.694 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.2 t0 -95.97 157.97 15.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.504 ' CD ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -150.07 -49.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' ILE . 2.4 tt -150.0 57.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.962 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.82 -48.76 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.83 159.3 16.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.0 p90 -164.25 -178.1 5.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -146.95 136.88 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.0 129.83 37.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.811 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mm -98.86 124.59 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.738 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 4.2 p -118.47 -176.24 3.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.8 mmm -89.76 136.91 28.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -31.01 122.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.755 2.97 . . . . 0.0 112.77 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.02 -10.02 51.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.331 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.85 108.85 19.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.716 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -166.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.51 -176.85 18.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.545 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.01 -35.04 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.14 25.36 10.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.068 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.6 OUTLIER 59.54 78.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.758 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -160.47 42.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 37' ' ' GLU . 12.8 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -108.57 -33.79 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 -17.0 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.274 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.86 100.01 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 49.8 Cg_endo -68.68 -9.52 26.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.51 2.14 . . . . 0.0 112.738 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 33.4 m -48.92 170.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.807 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -102.43 -48.04 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -90.04 -91.86 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.28 36.37 0.67 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.687 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -72.22 172.3 10.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.504 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -96.88 178.61 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 15' ' ' THR . 13.8 t -95.78 155.83 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.69 79.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.41 158.62 22.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.81 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.1 mm100 -144.42 -82.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -146.85 83.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.996 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.67 -35.59 4.33 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.94 157.31 16.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 13.3 t80 -158.63 144.38 16.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 5.6 mt-30 -150.05 149.8 30.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.16 127.82 54.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.777 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.9 mm -89.73 122.2 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -128.38 -158.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.421 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.479 ' HB3' ' CD2' ' A' ' 31' ' ' TYR . 8.1 tpt -89.62 133.13 34.96 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.381 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.5 Cg_exo -30.26 115.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.659 2.906 . . . . 0.0 113.003 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.2 23.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.21 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 27.6 m-85 -89.82 75.92 7.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.566 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.92 -175.73 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.663 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.41 -115.66 3.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 35' ' ' TYR . 11.4 m -138.36 -45.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 111.411 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 34' ' ' VAL . 11.9 m-85 -127.69 31.93 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.178 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.1 t 59.41 85.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.876 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.824 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -175.32 34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.132 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' C ' ' A' ' 37' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.828 0.347 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -94.73 -32.05 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.1 p -136.12 12.6 3.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.306 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.18 118.15 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.9 Cg_endo -74.77 -16.7 20.68 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.466 2.111 . . . . 0.0 112.364 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.0 m -57.91 -166.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 -42.01 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.571 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -89.95 -88.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.208 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.12 43.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.978 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -95.84 158.28 15.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.9 158.36 15.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.714 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.03 148.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.35 74.33 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.716 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.7 t0 -95.34 131.12 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.656 ' HB3' HD12 ' A' ' 20' ' ' ILE . 14.8 mt-30 -125.4 -68.26 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -127.59 72.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -54.8 4.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -90.02 162.2 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 46.3 p90 -157.73 179.83 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 141.01 22.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 1.7 m -89.84 133.9 34.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.14 123.07 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.9 p -119.75 -168.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.444 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 9.4 mmm -89.58 131.88 38.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 2.9 Cg_exo -34.93 97.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.432 2.754 . . . . 0.0 112.645 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.92 -13.3 4.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.374 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.85 106.94 18.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.98 -168.23 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.82 -175.95 16.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.0 -29.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -128.7 30.55 5.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.2 m 60.79 91.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE2' HD11 ' A' ' 38' ' ' ILE . 1.8 pp20? -169.73 33.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 37' ' ' GLU . 16.2 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 0.0 111.088 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.5 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.78 0.324 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -101.29 -31.95 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -104.93 -30.78 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.83 91.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 23' ' ' PHE . 69.6 Cg_exo -51.59 -22.25 12.46 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.535 2.157 . . . . 0.0 112.578 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.9 m -45.95 164.26 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -109.91 -40.57 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -89.83 -94.14 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -150.24 41.07 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.07 171.78 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.375 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -97.1 174.1 6.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 15' ' ' THR . 43.4 t -105.44 133.92 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.014 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.69 65.75 1.4 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -108.48 37.09 2.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -117.28 30.84 7.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.287 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 20' ' ' ILE . 22.3 mt -150.05 49.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.033 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.32 -59.46 3.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.25 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -107.75 162.45 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.563 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' CE2' ' HG2' ' A' ' 9' ' ' PRO . 48.8 t80 -106.31 146.58 30.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.29 134.91 17.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.003 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 m -89.85 125.89 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.1 mm -89.53 121.23 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 21.2 p -132.55 -162.68 1.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.015 0.436 . . . . 0.0 111.875 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.528 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.71 134.87 31.41 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.001 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 6.2 Cg_endo -48.17 85.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.0 112.342 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 165.5 -29.63 0.21 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.24 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -89.89 104.98 17.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.92 -168.36 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.816 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 114.3 -164.03 12.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 m -92.05 -31.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 14.7 m-85 -122.5 24.38 9.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.44 90.15 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.212 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.844 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER 176.52 33.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.523 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 37' ' ' GLU . 2.1 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.756 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -35.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -135.55 8.16 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.87 101.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.574 0.226 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 66.3 Cg_endo -72.74 -5.85 17.94 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.485 2.124 . . . . 0.0 112.759 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.7 m -56.23 -171.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -113.52 -58.74 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.991 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.65 -145.47 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.454 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.56 54.77 3.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.046 0.451 . . . . 0.0 110.636 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -98.27 172.2 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.65 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' H ' HG22 ' A' ' 15' ' ' THR . 31.3 p -100.17 152.68 19.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 tp -163.31 78.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 25.4 t0 -112.55 136.17 52.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -97.57 -69.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 21' ' ' GLY . 18.1 pt -140.28 -42.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.392 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' N ' HG13 ' A' ' 20' ' ' ILE . . . -134.83 -35.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.923 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -89.78 121.16 31.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 7.1 t80 -100.24 147.19 26.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.765 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.413 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 tt0 -145.88 141.24 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 m -115.54 134.25 55.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.73 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.3 mm -89.77 121.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 p -130.03 -166.7 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.382 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -89.64 135.45 30.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.844 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 4.6 Cg_exo -38.96 121.65 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.044 2.496 . . . . 0.0 112.386 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.31 -16.42 27.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.233 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -89.84 88.85 7.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 110.492 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.9 -179.61 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.268 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.934 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 122.68 -158.06 17.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.534 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.91 -32.57 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -135.66 28.17 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.676 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.83 86.31 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.836 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -177.11 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.934 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.556 0.217 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.05 -32.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 111.252 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -115.39 -13.68 11.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.632 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 63.4 97.88 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.659 0.266 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 57.3 Cg_endo -69.68 -12.93 34.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.575 2.183 . . . . 0.0 112.775 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 9.9 m -57.64 -169.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -114.47 -54.84 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -89.77 -141.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.491 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.0 38.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 111.18 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -76.01 169.97 17.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.45 169.63 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 p -102.56 136.49 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.69 87.06 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -113.28 164.53 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.777 ' HB3' HD12 ' A' ' 20' ' ' ILE . 23.5 mt-30 -147.55 -65.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.4 mp -139.44 -54.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 26.82 1.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.52 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.56 88.82 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 44.5 t80 -90.27 145.38 25.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.06 152.37 34.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 m -113.99 129.98 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.76 121.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 p -128.75 -167.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.393 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.43 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.5 mmm -89.78 130.43 42.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.223 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.43 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 3.8 Cg_exo -38.81 98.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 112.285 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.31 -11.55 3.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.398 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -89.72 104.34 16.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -178.42 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.96 -172.37 15.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.82 -30.49 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -124.83 28.29 6.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m 60.26 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.673 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -158.72 37.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 37' ' ' GLU . 26.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.828 0.347 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.41 -36.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -122.51 -2.79 8.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.503 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 60.12 103.48 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 110.743 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 46.3 Cg_endo -68.75 -9.27 25.72 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.342 2.028 . . . . 0.0 112.828 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.7 m -58.01 -165.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -134.64 -43.32 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -89.64 -86.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.128 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -150.13 27.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.3 155.94 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.268 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -94.96 178.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' H ' HG22 ' A' ' 15' ' ' THR . 31.5 p -105.96 142.75 35.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.67 87.85 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 7.3 t70 -125.96 78.93 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -150.26 25.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.11 35.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.43 10.04 59.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.646 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.19 151.39 32.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.722 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 5.3 t80 -117.77 133.94 55.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.75 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -150.18 139.42 21.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 m -89.88 133.9 34.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 mm -92.74 120.84 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.721 0.296 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 8.3 p -115.65 -166.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.376 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.401 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -89.82 148.47 39.91 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 10.3 Cg_endo -50.79 93.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.804 2.336 . . . . 0.0 111.864 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.42 -8.52 5.32 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -89.82 121.66 32.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.682 0.277 . . . . 0.0 110.428 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -107.64 -165.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.33 -166.64 12.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.473 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 35' ' ' TYR . 33.0 m -89.8 -43.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.819 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-85 -113.12 32.52 5.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.018 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER 56.64 80.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.671 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -159.46 44.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.462 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 37' ' ' GLU . 19.2 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 98.3 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.842 0.353 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.3 -32.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -122.62 12.94 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.346 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.05 109.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.608 0.242 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 56.8 Cg_endo -69.88 -9.58 26.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.367 2.044 . . . . 0.0 112.529 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.4 m -57.87 -166.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.93 -41.58 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.322 . . . . 0.0 111.496 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.8 -88.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.052 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.19 29.79 0.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.66 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -78.6 156.49 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -89.94 167.04 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -103.64 136.69 42.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 17' ' ' LEU . 6.4 tt -133.0 80.28 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 8.6 t0 -93.15 138.92 31.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.64 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.5 mt-30 -124.17 -73.97 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 19' ' ' GLN . 2.8 mp -132.67 69.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.8 -44.37 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.0 158.01 16.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 26.9 p90 -155.38 -179.47 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -148.07 142.01 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.832 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.26 125.65 36.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.0 mm -89.87 122.53 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.657 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 p -124.32 -164.72 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.487 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.6 136.73 29.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.51 97.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.116 2.544 . . . . 0.0 112.457 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.65 -13.98 4.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.236 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.78 106.24 18.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.1 179.67 4.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.901 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 125.41 -160.77 19.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.374 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 m -89.96 -32.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.352 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.58 29.45 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.753 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.37 82.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.829 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -172.15 32.94 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.901 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.831 0.348 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.57 -30.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -139.84 22.58 2.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 60.87 115.17 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . 84.7 Cg_endo -75.69 -14.17 19.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.196 . . . . 0.0 112.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -50.59 174.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -110.22 -44.41 3.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.348 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -89.98 -90.33 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.076 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -150.29 33.28 0.65 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.701 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -75.81 158.89 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.326 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -93.92 152.43 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.81 138.2 31.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.16 90.08 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 10.8 p30 -89.79 147.68 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -129.49 -75.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.22 66.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.22 -27.37 17.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.469 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -122.79 147.03 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 5.4 p90 -134.58 -175.41 3.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 138.0 20.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 m -89.79 126.62 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.629 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.79 121.28 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -129.14 -165.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.177 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.63 135.6 30.55 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.8 Cg_endo -41.28 103.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.101 2.534 . . . . 0.0 112.617 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.07 -11.0 5.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.494 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.85 95.49 10.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.733 0.301 . . . . 0.0 110.642 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.52 -167.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.7 -155.31 17.3 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.434 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.85 -32.09 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.746 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 13.9 m-85 -135.6 50.0 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.29 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 16.8 p 43.76 51.78 6.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.602 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.4 pp20? -122.35 37.22 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 37' ' ' GLU . 28.8 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.029 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.655 0.264 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.07 -36.59 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.3 m -105.78 -7.96 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.285 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 62.03 91.45 0.08 OUTLIER Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.069 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 37.0 Cg_endo -65.64 -19.21 59.97 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.53 2.154 . . . . 0.0 112.248 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.45 -169.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -113.35 -59.18 2.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -89.86 -146.42 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.39 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.85 48.41 1.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -80.99 176.6 9.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.077 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -117.06 143.0 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 31.7 p -89.93 134.76 34.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 86.27 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.92 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -118.75 156.86 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 21' ' ' GLY . 4.1 tt -135.5 -45.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.286 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -155.26 36.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.618 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -149.82 117.15 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 22.8 t80 -120.89 136.6 54.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -150.06 132.05 15.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 m -90.78 123.09 34.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.491 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.8 mm -89.82 122.64 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.61 -167.84 1.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.578 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.446 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 13.1 mmm -89.7 130.9 41.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.306 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.9 Cg_exo -38.13 92.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.286 2.657 . . . . 0.0 112.363 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.45 -17.5 1.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.364 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 66.4 m-85 -89.72 109.12 20.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.12 -176.23 3.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.11 -160.25 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.418 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.83 -32.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 110.732 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 1.8 m-85 -129.5 30.9 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.629 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.1 m 61.19 81.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.711 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -160.52 39.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.3 mm . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.811 0.339 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 t -80.85 149.89 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -155.9 -46.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -31.14 14.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 m -97.41 40.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.17 -27.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 p -110.97 -23.0 11.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.29 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 51.1 Cg_exo -55.13 -20.15 23.11 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.665 2.243 . . . . 0.0 112.569 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -48.71 171.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.624 0.249 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -39.01 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 111.682 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -89.9 -89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -150.19 35.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 110.982 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -84.2 160.89 20.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -176.08 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.56 153.6 19.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 26' ' ' ILE . 3.1 tt -161.23 89.67 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 5.4 t0 -139.72 138.85 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.29 -59.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -143.34 -45.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -151.64 39.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.591 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -149.99 79.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.792 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 3.8 t80 -89.53 130.86 35.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -150.22 139.0 20.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 m -89.77 133.09 34.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 31.9 mm -89.85 122.38 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 25.8 p -129.67 -164.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.572 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' HG2' ' A' ' 29' ' ' PRO . 3.7 tpt -89.7 140.44 28.02 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.502 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HG2' ' HE2' ' A' ' 28' ' ' MET . 9.2 Cg_endo -50.53 89.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.098 2.532 . . . . 0.0 111.828 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.86 -20.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -89.63 122.63 32.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 110.366 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -102.46 -174.85 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.87 -173.84 15.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.85 -30.59 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.42 25.74 8.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.8 OUTLIER 60.41 90.16 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.746 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -177.0 42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.746 HD13 ' O ' ' A' ' 37' ' ' GLU . 13.8 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.13 139.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.044 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -59.78 174.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' OE2' ' CE2' ' A' ' 23' ' ' PHE . 4.8 mm-40 -129.72 31.51 4.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.978 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.94 19.31 1.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 tt -114.33 21.38 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.302 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 m -150.1 -42.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.155 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.4 88.97 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.745 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 59.4 Cg_endo -71.92 -5.67 17.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.746 2.297 . . . . 0.0 112.9 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.1 m -56.71 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -125.26 -43.61 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 -91.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.061 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.12 31.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.53 165.45 22.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.497 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.42 171.13 8.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.74 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 p -92.24 153.84 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.111 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -158.02 77.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.7 t70 -126.57 142.11 51.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -150.07 -71.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.53 38.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 11.96 61.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.71 70.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.658 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 2.0 t80 -76.91 129.52 36.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.191 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.32 136.03 18.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.6 m -93.1 139.99 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.342 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.3 mm -99.05 121.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -124.06 -170.72 2.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.208 0.528 . . . . 0.0 112.099 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.457 ' HE3' ' HD2' ' A' ' 29' ' ' PRO . 1.6 mtp -89.65 160.49 41.44 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.424 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' ' HE3' ' A' ' 28' ' ' MET . 9.8 Cg_endo -50.07 125.0 13.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.928 2.419 . . . . 0.0 111.668 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.19 -5.67 63.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.405 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.79 104.59 17.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.73 0.3 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.73 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.342 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.09 -169.86 13.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.431 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -89.65 -29.91 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.768 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -126.61 29.06 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.712 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.4 m 60.98 91.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.565 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.658 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.1 pp20? -177.36 42.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.056 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.7 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.103 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.868 0.366 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 5' ' ' CYS . 21.5 t -88.85 103.18 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -94.0 11.1 30.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.276 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.92 -44.24 6.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.459 ' H ' HG12 ' A' ' 2' ' ' VAL . 85.5 m -100.79 29.86 4.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.908 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 tt -92.41 -30.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.8 t -116.18 17.36 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.32 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 53.94 97.55 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 65.4 Cg_endo -72.43 -16.77 27.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.506 2.138 . . . . 0.0 112.506 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 14.3 m -56.55 -169.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -57.65 2.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.76 -145.88 0.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.76 53.34 2.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -88.95 -178.96 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.234 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -124.89 140.29 53.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -89.96 145.32 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 tp -141.41 87.8 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.013 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 14.7 t70 -90.01 150.5 22.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 20' ' ' ILE . 16.8 mt-30 -126.92 -60.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.645 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -137.95 -63.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.837 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.17 4.52 5.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.805 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -150.22 162.33 40.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.69 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 33.1 p90 -148.82 -177.1 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.8 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -143.21 138.77 29.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.765 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -93.75 123.68 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.075 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.413 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.1 mm -89.81 122.62 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.547 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -129.1 -165.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.526 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.0 mmm -89.84 128.16 51.27 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.526 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.0 Cg_endo -40.82 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.945 2.43 . . . . 0.0 112.267 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.04 -18.79 1.76 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.375 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.74 96.39 10.67 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.77 0.319 . . . . 0.0 110.421 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -174.89 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.47 -159.36 14.75 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.261 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 m -89.87 -36.24 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.52 30.57 5.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.577 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 62.66 76.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.6 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -150.9 41.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.8 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.906 0.384 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 t -97.46 84.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -107.9 -47.25 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.06 -32.13 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -95.77 35.34 1.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 tp -95.56 -32.2 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -144.76 15.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.389 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.98 112.31 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 69.6 Cg_endo -73.58 -18.05 22.9 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.431 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m -63.04 -175.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.39 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -55.52 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -89.33 -168.43 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.81 52.49 2.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.05 176.73 4.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -89.96 165.28 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.32 123.15 37.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.968 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.69 HD12 HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -146.86 87.19 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 31.7 t70 -135.81 161.24 36.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.41 -65.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 21' ' ' GLY . 3.1 tt -150.08 -46.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -123.77 -33.85 0.78 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.725 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.88 106.66 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.99 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 9.7 t80 -113.06 121.51 44.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.09 141.18 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.972 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.407 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 1.7 m -105.32 155.68 18.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 17' ' ' LEU . 31.1 mm -89.8 120.59 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.046 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 p -120.98 -170.63 2.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.562 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.455 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 8.3 mmm -89.86 129.95 44.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.114 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 4.5 Cg_exo -38.81 91.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.176 2.584 . . . . 0.0 112.371 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 150.34 -24.14 1.09 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.107 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 17.1 m-30 -89.84 83.86 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.469 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -90.06 -177.1 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.845 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.11 -154.86 16.28 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.565 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.91 -30.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 1.1 m-85 -131.24 31.36 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m 54.47 74.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.837 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -166.93 30.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.149 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.845 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.8 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.739 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.14 91.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -79.26 80.19 5.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.06 -71.55 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 m -122.49 29.21 7.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -103.45 -33.1 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -117.76 -13.32 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.454 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.62 97.36 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.61 0.243 . . . . 0.0 110.82 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -66.35 -12.95 37.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.487 2.125 . . . . 0.0 112.638 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 21.3 m -55.85 175.76 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.757 0.313 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -102.82 -59.44 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.76 -145.4 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.418 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.76 50.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.939 0.399 . . . . 0.0 110.827 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -91.26 158.62 16.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.07 163.07 15.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 p -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tt -142.65 96.54 2.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 27.7 t0 -128.06 131.79 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.51 -74.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.96 73.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.35 -29.51 11.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.96 134.71 34.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.1 t80 -134.92 141.13 46.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.975 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -150.08 131.45 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.86 129.87 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 25.7 mm -89.83 121.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 p -126.93 -167.03 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.414 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 10.1 tpt -89.71 120.43 69.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.34 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 83.9 Cg_exo -33.55 95.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.223 2.615 . . . . 0.0 112.725 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.61 -12.83 2.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.52 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 28' ' ' MET . 38.9 m-85 -89.72 107.37 19.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.828 0.346 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -175.31 4.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.361 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.5 -166.63 12.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.41 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.82 -32.37 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.669 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -128.23 29.08 5.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.537 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.4 m 61.09 76.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 11' ' ' GLN . 1.8 pp20? -141.1 28.77 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.4 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.64 124.54 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.509 ' H ' HD11 ' A' ' 6' ' ' ILE . 1.6 m-20 -97.91 -171.36 2.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.33 -31.1 11.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.9 m -96.1 61.76 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.509 HD11 ' H ' ' A' ' 3' ' ' ASN . 31.8 mm -91.66 -40.29 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -138.79 18.61 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 57.08 104.37 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.1 Cg_endo -70.08 -19.22 34.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.474 2.116 . . . . 0.0 112.342 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 14.1 m -54.64 -178.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.859 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -107.77 -58.43 1.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.07 0.462 . . . . 0.0 110.975 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -89.81 -144.94 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.508 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.81 51.94 2.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -97.42 147.59 24.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -90.39 157.8 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 26.5 p -91.61 151.11 20.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 87.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 17.6 t0 -127.52 150.25 49.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -132.98 -54.3 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 21' ' ' GLY . 2.1 pp -149.42 -46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.63 ' N ' HD12 ' A' ' 20' ' ' ILE . . . -150.82 34.75 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.529 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -150.01 108.99 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.3 t80 -114.68 135.43 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.99 130.38 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.0 m -90.45 130.25 36.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.88 123.33 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.446 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.27 -169.72 2.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.437 . . . . 0.0 111.629 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.466 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 9.0 mmm -89.97 129.41 46.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.9 Cg_endo -39.63 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.2 2.6 . . . . 0.0 112.421 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 152.99 -25.7 0.81 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.25 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.1 m-30 -89.79 111.91 23.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.666 0.269 . . . . 0.0 110.463 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -110.6 -175.97 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.149 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.06 -151.4 17.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.91 -31.95 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 110.922 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.7 m-85 -133.77 28.85 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.725 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.65 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.634 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.68 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.4 pp20? -171.0 40.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.001 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.3 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.12 132.84 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -170.57 150.14 3.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 31.23 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.1 23.53 13.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.11 -35.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.148 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -106.77 -20.1 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 62.76 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 44.7 Cg_endo -68.3 -9.74 26.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.84 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 15.8 m -58.85 -163.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.08 -45.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -90.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -150.12 29.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 110.67 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.1 162.34 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 171.41 9.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.88 124.59 49.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.89 89.14 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -113.48 168.58 9.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -150.08 -65.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.715 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -150.16 -45.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -133.83 -33.52 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.891 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -89.77 152.3 21.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.057 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 11.5 t80 -155.79 139.35 15.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.19 138.87 20.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.0 m -89.94 141.04 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 27.6 mm -99.51 122.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 5.2 p -119.06 -171.44 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.687 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 12.0 mmm -89.8 132.1 37.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 5.7 Cg_exo -36.49 92.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.383 2.722 . . . . 0.0 112.454 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.26 -23.28 1.56 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.184 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -89.8 122.88 33.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 110.418 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -164.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.113 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.38 -171.79 14.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.436 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.91 -32.86 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.48 24.19 11.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.33 81.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.645 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -175.18 49.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.283 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 37' ' ' GLU . 14.6 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.179 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.97 136.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -151.41 -58.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.97 28.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 54.2 m -111.14 22.98 14.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.93 -31.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.24 -21.83 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 66.11 105.88 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 80.2 Cg_endo -75.47 -25.33 11.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.604 2.203 . . . . 0.0 112.179 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 6.2 m -51.35 165.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.759 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -101.02 -56.44 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.107 0.479 . . . . 0.0 111.101 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -89.68 -143.39 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.74 59.65 4.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -107.91 151.32 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -95.89 167.1 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 p -95.43 157.52 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.801 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -149.12 87.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -120.93 138.63 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -122.91 -78.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -150.06 30.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.235 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.68 -37.91 0.54 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.584 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.92 133.63 34.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 110.977 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 2.0 t80 -135.94 124.43 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -150.15 141.23 23.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 135.41 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.725 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.466 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.2 mm -96.25 123.08 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.595 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 7.3 p -126.99 -165.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.521 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.64 136.56 29.41 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.328 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.521 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.96 103.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.97 2.447 . . . . 0.0 112.374 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.13 -20.94 3.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.128 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.89 112.69 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.278 . . . . 0.0 110.252 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.29 -165.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -168.54 12.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.263 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 m -89.88 -29.97 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.6 m-85 -125.23 27.85 6.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 61.21 86.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.732 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -174.54 41.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 37' ' ' GLU . 15.6 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.213 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.812 0.339 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.43 86.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -118.09 33.24 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 -38.45 11.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.1 m -98.05 30.05 3.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.45 -31.16 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.51 -27.76 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 63.57 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 58.4 Cg_endo -70.47 -14.1 33.5 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.0 m -56.49 -173.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.741 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 3.6 tm0? -106.55 -60.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -89.75 -147.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.5 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.68 59.56 4.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.042 0.448 . . . . 0.0 110.684 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -88.85 177.18 6.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.3 177.68 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.428 ' H ' HG22 ' A' ' 15' ' ' THR . 40.3 t -102.57 149.4 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 72.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -108.26 145.32 34.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -122.65 -72.26 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.3 -66.72 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.99 -27.83 3.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.589 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.94 159.01 17.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 53.1 t80 -146.35 145.88 30.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -144.44 157.92 44.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.93 127.87 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mm -89.87 122.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.442 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.3 p -128.04 -168.18 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.581 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 9.7 mmm -89.83 129.88 44.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 3.5 Cg_exo -38.94 91.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.198 2.599 . . . . 0.0 112.383 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.29 -26.3 0.98 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.134 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.2 m-30 -89.85 117.86 29.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.327 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -118.08 -175.62 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 111.203 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.44 -152.52 16.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.86 -31.27 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -132.26 28.97 4.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.52 90.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -170.86 35.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.4 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.054 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.19 112.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -89.19 95.09 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -100.41 -32.86 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 62.8 m -98.18 29.09 3.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -97.97 -34.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -101.91 -29.94 11.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 62.51 115.75 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 68.5 Cg_endo -82.44 1.54 9.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.699 2.266 . . . . 0.0 112.316 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 m -60.13 -165.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.773 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -45.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -89.98 -88.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -150.27 30.19 0.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.763 0.315 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.52 168.41 17.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -101.08 -165.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' H ' HG22 ' A' ' 15' ' ' THR . 47.4 t -129.23 146.2 51.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -160.71 100.66 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.616 ' HA ' ' CB ' ' A' ' 23' ' ' PHE . 4.8 p-10 -92.48 176.01 6.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -147.22 -62.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 pt -149.69 77.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.07 -48.05 2.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.37 163.14 13.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 110.819 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 18' ' ' ASP . 1.8 p90 -155.78 -179.64 8.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -147.68 155.03 41.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' C ' HD12 ' A' ' 26' ' ' ILE . 18.8 m -89.39 141.65 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.825 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 26' ' ' ILE . 1.3 mp -101.49 128.4 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.533 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.8 p -118.49 -171.6 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.152 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.427 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 3.0 tpt -89.61 137.12 28.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.9 Cg_exo -36.98 104.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.172 2.581 . . . . 0.0 112.753 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.87 -9.76 7.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.512 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.89 111.95 23.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.03 -168.15 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.75 176.07 21.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.447 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.02 -29.85 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.307 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.5 m-85 -117.68 24.92 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 57.74 82.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.748 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -165.96 42.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 37' ' ' GLU . 16.4 mm . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.159 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.03 127.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -106.96 139.88 40.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -96.37 -27.46 14.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.023 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.3 m -97.07 36.4 1.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -97.82 -33.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -5.35 11.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.325 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.04 118.92 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.82 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.2 Cg_endo -75.92 -22.06 13.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.533 2.156 . . . . 0.0 112.408 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.1 m -58.84 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.15 -43.43 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.401 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.88 -88.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.082 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -150.24 27.28 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -69.91 156.92 38.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.5 m -90.0 145.29 25.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 p -90.24 135.37 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tp -127.36 79.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.694 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.2 t0 -95.97 157.97 15.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.504 ' CD ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -150.07 -49.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' ILE . 2.4 tt -150.0 57.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.962 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.82 -48.76 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.83 159.3 16.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.0 p90 -164.25 -178.1 5.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -146.95 136.88 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.0 129.83 37.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.811 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mm -98.86 124.59 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.738 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 4.2 p -118.47 -176.24 3.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.8 mmm -89.76 136.91 28.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -31.01 122.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.755 2.97 . . . . 0.0 112.77 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.02 -10.02 51.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.331 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.85 108.85 19.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.716 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -166.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.51 -176.85 18.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.545 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.01 -35.04 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.14 25.36 10.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.068 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.6 OUTLIER 59.54 78.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.758 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -160.47 42.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 37' ' ' GLU . 12.8 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.0 t -69.15 126.31 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -97.4 42.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 3.6 tp10 -98.94 -37.99 9.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -100.97 27.68 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -108.57 -33.79 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 -17.0 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.274 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.86 100.01 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 49.8 Cg_endo -68.68 -9.52 26.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.51 2.14 . . . . 0.0 112.738 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 33.4 m -48.92 170.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.807 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -102.43 -48.04 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -90.04 -91.86 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.28 36.37 0.67 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.687 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -72.22 172.3 10.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.504 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -96.88 178.61 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 15' ' ' THR . 13.8 t -95.78 155.83 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.69 79.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.41 158.62 22.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.81 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.1 mm100 -144.42 -82.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -146.85 83.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.996 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.67 -35.59 4.33 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.94 157.31 16.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 13.3 t80 -158.63 144.38 16.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 5.6 mt-30 -150.05 149.8 30.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.16 127.82 54.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.777 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.9 mm -89.73 122.2 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -128.38 -158.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.421 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.479 ' HB3' ' CD2' ' A' ' 31' ' ' TYR . 8.1 tpt -89.62 133.13 34.96 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.381 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.5 Cg_exo -30.26 115.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.659 2.906 . . . . 0.0 113.003 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.2 23.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.21 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 27.6 m-85 -89.82 75.92 7.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.566 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.92 -175.73 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.663 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.41 -115.66 3.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 35' ' ' TYR . 11.4 m -138.36 -45.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 111.411 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 34' ' ' VAL . 11.9 m-85 -127.69 31.93 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.178 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.1 t 59.41 85.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.876 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.824 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -175.32 34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.132 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' C ' ' A' ' 37' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.61 125.96 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.193 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 59.58 28.84 18.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -143.16 -48.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.806 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.6 m -103.73 29.37 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -94.73 -32.05 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.1 p -136.12 12.6 3.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.306 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.18 118.15 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.9 Cg_endo -74.77 -16.7 20.68 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.466 2.111 . . . . 0.0 112.364 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.0 m -57.91 -166.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 -42.01 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.571 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -89.95 -88.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.208 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.12 43.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.978 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -95.84 158.28 15.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.9 158.36 15.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.714 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.03 148.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.35 74.33 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.716 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.7 t0 -95.34 131.12 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.656 ' HB3' HD12 ' A' ' 20' ' ' ILE . 14.8 mt-30 -125.4 -68.26 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -127.59 72.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -54.8 4.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -90.02 162.2 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 46.3 p90 -157.73 179.83 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 141.01 22.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 1.7 m -89.84 133.9 34.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.14 123.07 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.9 p -119.75 -168.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.444 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 9.4 mmm -89.58 131.88 38.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 2.9 Cg_exo -34.93 97.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.432 2.754 . . . . 0.0 112.645 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.92 -13.3 4.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.374 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.85 106.94 18.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.98 -168.23 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.82 -175.95 16.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.0 -29.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -128.7 30.55 5.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.2 m 60.79 91.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE2' HD11 ' A' ' 38' ' ' ILE . 1.8 pp20? -169.73 33.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 37' ' ' GLU . 16.2 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 0.0 111.088 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.3 p -70.38 65.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -124.74 129.68 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -109.71 -29.49 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.968 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.5 m -97.84 30.02 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.99 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -101.29 -31.95 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -104.93 -30.78 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.83 91.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 23' ' ' PHE . 69.6 Cg_exo -51.59 -22.25 12.46 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.535 2.157 . . . . 0.0 112.578 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.9 m -45.95 164.26 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -109.91 -40.57 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -89.83 -94.14 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -150.24 41.07 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.07 171.78 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.375 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -97.1 174.1 6.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 15' ' ' THR . 43.4 t -105.44 133.92 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.014 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.69 65.75 1.4 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -108.48 37.09 2.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -117.28 30.84 7.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.287 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 20' ' ' ILE . 22.3 mt -150.05 49.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.033 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.32 -59.46 3.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.25 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -107.75 162.45 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.563 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' CE2' ' HG2' ' A' ' 9' ' ' PRO . 48.8 t80 -106.31 146.58 30.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.29 134.91 17.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.003 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 m -89.85 125.89 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.1 mm -89.53 121.23 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 21.2 p -132.55 -162.68 1.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.015 0.436 . . . . 0.0 111.875 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.528 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.71 134.87 31.41 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.001 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 6.2 Cg_endo -48.17 85.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.0 112.342 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 165.5 -29.63 0.21 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.24 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -89.89 104.98 17.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.92 -168.36 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.816 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 114.3 -164.03 12.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 m -92.05 -31.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 14.7 m-85 -122.5 24.38 9.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.44 90.15 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.212 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.844 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER 176.52 33.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.523 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 37' ' ' GLU . 2.1 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.756 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' O ' HG12 ' A' ' 2' ' ' VAL . 21.0 t -97.74 35.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 59.2 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 -56.81 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.01 29.75 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -35.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -135.55 8.16 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.87 101.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.574 0.226 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 66.3 Cg_endo -72.74 -5.85 17.94 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.485 2.124 . . . . 0.0 112.759 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.7 m -56.23 -171.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -113.52 -58.74 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.991 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -89.65 -145.47 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.454 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.56 54.77 3.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.046 0.451 . . . . 0.0 110.636 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -98.27 172.2 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.65 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' H ' HG22 ' A' ' 15' ' ' THR . 31.3 p -100.17 152.68 19.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 tp -163.31 78.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 25.4 t0 -112.55 136.17 52.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -97.57 -69.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 21' ' ' GLY . 18.1 pt -140.28 -42.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.392 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' N ' HG13 ' A' ' 20' ' ' ILE . . . -134.83 -35.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.923 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -89.78 121.16 31.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 7.1 t80 -100.24 147.19 26.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.765 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.413 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 tt0 -145.88 141.24 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 m -115.54 134.25 55.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.73 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.3 mm -89.77 121.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 p -130.03 -166.7 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.382 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -89.64 135.45 30.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.844 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 4.6 Cg_exo -38.96 121.65 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.044 2.496 . . . . 0.0 112.386 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.31 -16.42 27.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.233 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -89.84 88.85 7.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 110.492 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.9 -179.61 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.268 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.934 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 122.68 -158.06 17.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.534 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.91 -32.57 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -135.66 28.17 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.676 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.83 86.31 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.836 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -177.11 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.934 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.45 133.91 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.02 167.2 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -113.89 -32.04 6.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.79 15.56 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.05 -32.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 111.252 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -115.39 -13.68 11.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.632 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 63.4 97.88 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.659 0.266 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 57.3 Cg_endo -69.68 -12.93 34.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.575 2.183 . . . . 0.0 112.775 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 9.9 m -57.64 -169.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -114.47 -54.84 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -89.77 -141.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.491 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.0 38.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 111.18 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -76.01 169.97 17.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.45 169.63 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 p -102.56 136.49 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.69 87.06 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -113.28 164.53 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.777 ' HB3' HD12 ' A' ' 20' ' ' ILE . 23.5 mt-30 -147.55 -65.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.4 mp -139.44 -54.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 26.82 1.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.52 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.56 88.82 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 44.5 t80 -90.27 145.38 25.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.06 152.37 34.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 m -113.99 129.98 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.76 121.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 p -128.75 -167.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.393 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.43 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.5 mmm -89.78 130.43 42.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.223 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 3.8 Cg_exo -38.81 98.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 112.285 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.31 -11.55 3.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.398 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -89.72 104.34 16.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -178.42 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.96 -172.37 15.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.82 -30.49 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -124.83 28.29 6.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m 60.26 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.673 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -158.72 37.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 37' ' ' GLU . 26.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.0 t0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.44 82.57 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -171.51 80.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.6 -62.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.1 m -121.78 25.57 9.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.04 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.41 -36.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -122.51 -2.79 8.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.503 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 60.12 103.48 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 110.743 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 46.3 Cg_endo -68.75 -9.27 25.72 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.342 2.028 . . . . 0.0 112.828 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.7 m -58.01 -165.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -134.64 -43.32 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -89.64 -86.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.128 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -150.13 27.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.3 155.94 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.268 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -94.96 178.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' H ' HG22 ' A' ' 15' ' ' THR . 31.5 p -105.96 142.75 35.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.67 87.85 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 7.3 t70 -125.96 78.93 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -150.26 25.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.11 35.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.43 10.04 59.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.646 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.19 151.39 32.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.722 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 5.3 t80 -117.77 133.94 55.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.75 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -150.18 139.42 21.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 m -89.88 133.9 34.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 mm -92.74 120.84 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.721 0.296 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 8.3 p -115.65 -166.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.376 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.401 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -89.82 148.47 39.91 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 10.3 Cg_endo -50.79 93.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.804 2.336 . . . . 0.0 111.864 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.42 -8.52 5.32 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -89.82 121.66 32.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.682 0.277 . . . . 0.0 110.428 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -107.64 -165.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.33 -166.64 12.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.473 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 35' ' ' TYR . 33.0 m -89.8 -43.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.819 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-85 -113.12 32.52 5.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.018 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER 56.64 80.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.671 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -159.46 44.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.462 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 37' ' ' GLU . 19.2 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.14 87.38 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.074 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 60.55 -174.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.93 -61.58 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 98.3 m -96.49 40.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.3 -32.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -122.62 12.94 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.346 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.05 109.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.608 0.242 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 56.8 Cg_endo -69.88 -9.58 26.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.367 2.044 . . . . 0.0 112.529 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.4 m -57.87 -166.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.93 -41.58 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.322 . . . . 0.0 111.496 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.8 -88.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.052 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.19 29.79 0.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.66 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -78.6 156.49 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -89.94 167.04 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -103.64 136.69 42.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 17' ' ' LEU . 6.4 tt -133.0 80.28 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 8.6 t0 -93.15 138.92 31.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.64 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.5 mt-30 -124.17 -73.97 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 19' ' ' GLN . 2.8 mp -132.67 69.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.8 -44.37 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.0 158.01 16.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 26.9 p90 -155.38 -179.47 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -148.07 142.01 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.832 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.26 125.65 36.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.0 mm -89.87 122.53 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.657 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 p -124.32 -164.72 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.487 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.6 136.73 29.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.51 97.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.116 2.544 . . . . 0.0 112.457 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.65 -13.98 4.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.236 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.78 106.24 18.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.1 179.67 4.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.901 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 125.41 -160.77 19.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.374 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 m -89.96 -32.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.352 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.58 29.45 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.753 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.37 82.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.829 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -172.15 32.94 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.901 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.31 137.2 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.36 -173.06 2.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.38 -48.42 5.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 m -113.74 82.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.57 -30.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -139.84 22.58 2.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 60.87 115.17 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . 84.7 Cg_endo -75.69 -14.17 19.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.196 . . . . 0.0 112.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -50.59 174.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -110.22 -44.41 3.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.348 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -89.98 -90.33 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.076 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -150.29 33.28 0.65 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.701 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -75.81 158.89 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.326 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -93.92 152.43 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.81 138.2 31.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.16 90.08 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 10.8 p30 -89.79 147.68 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -129.49 -75.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.22 66.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.22 -27.37 17.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.469 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -122.79 147.03 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 5.4 p90 -134.58 -175.41 3.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 138.0 20.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 m -89.79 126.62 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.629 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.79 121.28 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -129.14 -165.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.177 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.63 135.6 30.55 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.8 Cg_endo -41.28 103.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.101 2.534 . . . . 0.0 112.617 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.07 -11.0 5.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.494 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.85 95.49 10.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.733 0.301 . . . . 0.0 110.642 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.52 -167.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.7 -155.31 17.3 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.434 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.85 -32.09 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.746 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 13.9 m-85 -135.6 50.0 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.29 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 16.8 p 43.76 51.78 6.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.602 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.4 pp20? -122.35 37.22 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 37' ' ' GLU . 28.8 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.029 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.853 0.359 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.2 t -93.8 98.21 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.09 -168.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.9 -55.07 3.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.54 23.78 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.07 -36.59 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.3 m -105.78 -7.96 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.285 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 62.03 91.45 0.08 OUTLIER Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.069 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 37.0 Cg_endo -65.64 -19.21 59.97 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.53 2.154 . . . . 0.0 112.248 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.45 -169.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -113.35 -59.18 2.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -89.86 -146.42 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.39 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.85 48.41 1.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -80.99 176.6 9.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.077 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -117.06 143.0 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 31.7 p -89.93 134.76 34.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 86.27 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.92 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -118.75 156.86 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 21' ' ' GLY . 4.1 tt -135.5 -45.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.286 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -155.26 36.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.618 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -149.82 117.15 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 22.8 t80 -120.89 136.6 54.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -150.06 132.05 15.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 m -90.78 123.09 34.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.491 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.8 mm -89.82 122.64 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.61 -167.84 1.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.578 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.446 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 13.1 mmm -89.7 130.9 41.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.306 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.9 Cg_exo -38.13 92.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.286 2.657 . . . . 0.0 112.363 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.45 -17.5 1.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.364 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 66.4 m-85 -89.72 109.12 20.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.12 -176.23 3.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.11 -160.25 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.418 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.83 -32.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 110.732 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 1.8 m-85 -129.5 30.9 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.629 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.1 m 61.19 81.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.711 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -160.52 39.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.3 mm . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.845 0.355 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.17 -27.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 p -110.97 -23.0 11.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.29 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 51.1 Cg_exo -55.13 -20.15 23.11 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.665 2.243 . . . . 0.0 112.569 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -48.71 171.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.624 0.249 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -39.01 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 111.682 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -89.9 -89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -150.19 35.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 110.982 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -84.2 160.89 20.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -176.08 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.56 153.6 19.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 26' ' ' ILE . 3.1 tt -161.23 89.67 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 5.4 t0 -139.72 138.85 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.29 -59.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -143.34 -45.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -151.64 39.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.591 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -149.99 79.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.792 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 3.8 t80 -89.53 130.86 35.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -150.22 139.0 20.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 m -89.77 133.09 34.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 31.9 mm -89.85 122.38 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 25.8 p -129.67 -164.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.572 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' HG2' ' A' ' 29' ' ' PRO . 3.7 tpt -89.7 140.44 28.02 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.502 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HG2' ' HE2' ' A' ' 28' ' ' MET . 9.2 Cg_endo -50.53 89.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.098 2.532 . . . . 0.0 111.828 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.86 -20.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -89.63 122.63 32.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 110.366 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -102.46 -174.85 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.87 -173.84 15.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.85 -30.59 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.42 25.74 8.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.8 OUTLIER 60.41 90.16 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.746 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -177.0 42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.746 HD13 ' O ' ' A' ' 37' ' ' GLU . 13.8 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.653 0.263 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 tt -114.33 21.38 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.302 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 m -150.1 -42.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.155 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.4 88.97 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.745 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 59.4 Cg_endo -71.92 -5.67 17.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.746 2.297 . . . . 0.0 112.9 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.1 m -56.71 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -125.26 -43.61 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 -91.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.061 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.12 31.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.53 165.45 22.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.497 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.42 171.13 8.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.74 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 p -92.24 153.84 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.111 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -158.02 77.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.7 t70 -126.57 142.11 51.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -150.07 -71.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.53 38.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 11.96 61.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.71 70.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.658 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 2.0 t80 -76.91 129.52 36.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.191 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.32 136.03 18.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.6 m -93.1 139.99 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.342 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.3 mm -99.05 121.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -124.06 -170.72 2.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.208 0.528 . . . . 0.0 112.099 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.457 ' HE3' ' HD2' ' A' ' 29' ' ' PRO . 1.6 mtp -89.65 160.49 41.44 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.424 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' ' HE3' ' A' ' 28' ' ' MET . 9.8 Cg_endo -50.07 125.0 13.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.928 2.419 . . . . 0.0 111.668 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.19 -5.67 63.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.405 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.79 104.59 17.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.73 0.3 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.73 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.342 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.09 -169.86 13.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.431 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -89.65 -29.91 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.768 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -126.61 29.06 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.712 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.4 m 60.98 91.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.565 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.658 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.1 pp20? -177.36 42.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.056 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.7 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.103 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 85.5 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.859 0.361 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 tt -92.41 -30.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.8 t -116.18 17.36 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.32 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 53.94 97.55 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 65.4 Cg_endo -72.43 -16.77 27.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.506 2.138 . . . . 0.0 112.506 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 14.3 m -56.55 -169.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -57.65 2.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.76 -145.88 0.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.76 53.34 2.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -88.95 -178.96 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.234 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -124.89 140.29 53.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -89.96 145.32 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 tp -141.41 87.8 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.013 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 14.7 t70 -90.01 150.5 22.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 20' ' ' ILE . 16.8 mt-30 -126.92 -60.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.645 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -137.95 -63.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.837 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.17 4.52 5.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.805 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -150.22 162.33 40.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.69 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 33.1 p90 -148.82 -177.1 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.8 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 138.77 29.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.765 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -93.75 123.68 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.075 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.413 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.1 mm -89.81 122.62 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.547 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -129.1 -165.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.526 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.0 mmm -89.84 128.16 51.27 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.526 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.0 Cg_endo -40.82 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.945 2.43 . . . . 0.0 112.267 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.04 -18.79 1.76 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.375 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.74 96.39 10.67 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.77 0.319 . . . . 0.0 110.421 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -174.89 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.47 -159.36 14.75 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.261 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 m -89.87 -36.24 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.52 30.57 5.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.577 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 62.66 76.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.6 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -150.9 41.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.8 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.808 0.337 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 tp -95.56 -32.2 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -144.76 15.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.389 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.98 112.31 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 69.6 Cg_endo -73.58 -18.05 22.9 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.431 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m -63.04 -175.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.39 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -55.52 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -89.33 -168.43 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.81 52.49 2.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.05 176.73 4.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -89.96 165.28 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.32 123.15 37.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.968 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.69 HD12 HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -146.86 87.19 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 31.7 t70 -135.81 161.24 36.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.41 -65.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 21' ' ' GLY . 3.1 tt -150.08 -46.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.505 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -123.77 -33.85 0.78 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.725 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.88 106.66 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.99 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 9.7 t80 -113.06 121.51 44.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.09 141.18 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.972 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 1.7 m -105.32 155.68 18.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 17' ' ' LEU . 31.1 mm -89.8 120.59 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.046 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 p -120.98 -170.63 2.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.562 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.455 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 8.3 mmm -89.86 129.95 44.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.114 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 4.5 Cg_exo -38.81 91.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.176 2.584 . . . . 0.0 112.371 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 150.34 -24.14 1.09 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.107 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 17.1 m-30 -89.84 83.86 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.469 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -90.06 -177.1 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.845 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.11 -154.86 16.28 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.565 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.91 -30.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 1.1 m-85 -131.24 31.36 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m 54.47 74.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.837 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -166.93 30.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.149 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.845 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.8 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.739 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.79 0.329 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -103.45 -33.1 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -117.76 -13.32 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.454 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.62 97.36 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.61 0.243 . . . . 0.0 110.82 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -66.35 -12.95 37.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.487 2.125 . . . . 0.0 112.638 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 21.3 m -55.85 175.76 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.757 0.313 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -102.82 -59.44 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.76 -145.4 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.418 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.76 50.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.939 0.399 . . . . 0.0 110.827 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -91.26 158.62 16.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.07 163.07 15.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 p -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tt -142.65 96.54 2.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 27.7 t0 -128.06 131.79 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.51 -74.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.96 73.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.35 -29.51 11.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.96 134.71 34.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.1 t80 -134.92 141.13 46.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.975 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -150.08 131.45 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.86 129.87 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 25.7 mm -89.83 121.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 p -126.93 -167.03 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.414 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 10.1 tpt -89.71 120.43 69.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.34 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 83.9 Cg_exo -33.55 95.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.223 2.615 . . . . 0.0 112.725 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.61 -12.83 2.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.52 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 28' ' ' MET . 38.9 m-85 -89.72 107.37 19.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.828 0.346 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -175.31 4.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.361 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.5 -166.63 12.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.41 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.82 -32.37 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.669 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -128.23 29.08 5.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.537 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.4 m 61.09 76.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 11' ' ' GLN . 1.8 pp20? -141.1 28.77 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.4 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.941 0.4 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.66 -40.29 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -138.79 18.61 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 57.08 104.37 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.1 Cg_endo -70.08 -19.22 34.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.474 2.116 . . . . 0.0 112.342 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 14.1 m -54.64 -178.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.859 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -107.77 -58.43 1.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.07 0.462 . . . . 0.0 110.975 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -89.81 -144.94 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.508 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.81 51.94 2.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -97.42 147.59 24.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -90.39 157.8 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 26.5 p -91.61 151.11 20.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 87.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 17.6 t0 -127.52 150.25 49.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -132.98 -54.3 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 21' ' ' GLY . 2.1 pp -149.42 -46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.63 ' N ' HD12 ' A' ' 20' ' ' ILE . . . -150.82 34.75 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.529 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -150.01 108.99 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.3 t80 -114.68 135.43 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.99 130.38 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.0 m -90.45 130.25 36.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.88 123.33 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.446 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.27 -169.72 2.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.437 . . . . 0.0 111.629 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.466 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 9.0 mmm -89.97 129.41 46.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.9 Cg_endo -39.63 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.2 2.6 . . . . 0.0 112.421 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 152.99 -25.7 0.81 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.25 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.1 m-30 -89.79 111.91 23.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.666 0.269 . . . . 0.0 110.463 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -110.6 -175.97 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.149 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.06 -151.4 17.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.91 -31.95 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 110.922 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.7 m-85 -133.77 28.85 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.725 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.65 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.634 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.68 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.4 pp20? -171.0 40.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.001 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.3 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.719 0.295 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.11 -35.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.148 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -106.77 -20.1 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 62.76 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 44.7 Cg_endo -68.3 -9.74 26.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.84 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 15.8 m -58.85 -163.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.08 -45.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -90.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -150.12 29.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 110.67 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.1 162.34 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 171.41 9.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.88 124.59 49.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.89 89.14 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -113.48 168.58 9.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -150.08 -65.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.715 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -150.16 -45.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -133.83 -33.52 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.891 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -89.77 152.3 21.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.057 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 11.5 t80 -155.79 139.35 15.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.19 138.87 20.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.0 m -89.94 141.04 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 27.6 mm -99.51 122.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 5.2 p -119.06 -171.44 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.687 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 12.0 mmm -89.8 132.1 37.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 5.7 Cg_exo -36.49 92.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.383 2.722 . . . . 0.0 112.454 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.26 -23.28 1.56 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.184 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -89.8 122.88 33.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 110.418 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -164.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.113 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.38 -171.79 14.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.436 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.91 -32.86 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.48 24.19 11.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.33 81.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.645 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -175.18 49.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.283 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 37' ' ' GLU . 14.6 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.179 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 54.2 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.739 0.304 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.93 -31.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.24 -21.83 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 66.11 105.88 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 80.2 Cg_endo -75.47 -25.33 11.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.604 2.203 . . . . 0.0 112.179 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 6.2 m -51.35 165.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.759 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -101.02 -56.44 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.107 0.479 . . . . 0.0 111.101 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -89.68 -143.39 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.74 59.65 4.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -107.91 151.32 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -95.89 167.1 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 p -95.43 157.52 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.801 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -149.12 87.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -120.93 138.63 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -122.91 -78.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -150.06 30.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.235 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.68 -37.91 0.54 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.584 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.92 133.63 34.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 110.977 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 2.0 t80 -135.94 124.43 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -150.15 141.23 23.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 135.41 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.725 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.466 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.2 mm -96.25 123.08 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.595 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 7.3 p -126.99 -165.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.521 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.64 136.56 29.41 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.328 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.521 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.96 103.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.97 2.447 . . . . 0.0 112.374 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.13 -20.94 3.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.128 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.89 112.69 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.278 . . . . 0.0 110.252 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.29 -165.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -168.54 12.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.263 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 m -89.88 -29.97 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.6 m-85 -125.23 27.85 6.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 61.21 86.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.732 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -174.54 41.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 37' ' ' GLU . 15.6 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.213 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.45 -31.16 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.51 -27.76 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 63.57 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 58.4 Cg_endo -70.47 -14.1 33.5 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.0 m -56.49 -173.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.741 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 3.6 tm0? -106.55 -60.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -89.75 -147.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.5 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.68 59.56 4.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.042 0.448 . . . . 0.0 110.684 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -88.85 177.18 6.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.3 177.68 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.428 ' H ' HG22 ' A' ' 15' ' ' THR . 40.3 t -102.57 149.4 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 72.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -108.26 145.32 34.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -122.65 -72.26 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.3 -66.72 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.99 -27.83 3.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.589 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.94 159.01 17.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 53.1 t80 -146.35 145.88 30.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -144.44 157.92 44.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.93 127.87 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mm -89.87 122.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.442 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.3 p -128.04 -168.18 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.581 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 9.7 mmm -89.83 129.88 44.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 3.5 Cg_exo -38.94 91.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.198 2.599 . . . . 0.0 112.383 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.29 -26.3 0.98 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.134 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.2 m-30 -89.85 117.86 29.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.327 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -118.08 -175.62 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 111.203 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.44 -152.52 16.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.86 -31.27 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -132.26 28.97 4.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.52 90.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -170.86 35.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.4 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.054 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.756 0.312 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -97.97 -34.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -101.91 -29.94 11.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 62.51 115.75 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 68.5 Cg_endo -82.44 1.54 9.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.699 2.266 . . . . 0.0 112.316 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 m -60.13 -165.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.773 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -45.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -89.98 -88.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -150.27 30.19 0.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.763 0.315 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.52 168.41 17.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -101.08 -165.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' H ' HG22 ' A' ' 15' ' ' THR . 47.4 t -129.23 146.2 51.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -160.71 100.66 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.616 ' HA ' ' CB ' ' A' ' 23' ' ' PHE . 4.8 p-10 -92.48 176.01 6.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -147.22 -62.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 pt -149.69 77.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.07 -48.05 2.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.37 163.14 13.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 110.819 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 18' ' ' ASP . 1.8 p90 -155.78 -179.64 8.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -147.68 155.03 41.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' C ' HD12 ' A' ' 26' ' ' ILE . 18.8 m -89.39 141.65 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.825 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 26' ' ' ILE . 1.3 mp -101.49 128.4 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.533 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.8 p -118.49 -171.6 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.152 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.427 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 3.0 tpt -89.61 137.12 28.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.9 Cg_exo -36.98 104.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.172 2.581 . . . . 0.0 112.753 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.87 -9.76 7.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.512 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.89 111.95 23.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.03 -168.15 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.75 176.07 21.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.447 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.02 -29.85 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.307 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.5 m-85 -117.68 24.92 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 57.74 82.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.748 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -165.96 42.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 37' ' ' GLU . 16.4 mm . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.159 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.709 0.29 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -97.82 -33.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -5.35 11.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.325 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.04 118.92 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.82 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.2 Cg_endo -75.92 -22.06 13.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.533 2.156 . . . . 0.0 112.408 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.1 m -58.84 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.15 -43.43 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.401 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.88 -88.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.082 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -150.24 27.28 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -69.91 156.92 38.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.5 m -90.0 145.29 25.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 p -90.24 135.37 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tp -127.36 79.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.694 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.2 t0 -95.97 157.97 15.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.504 ' CD ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -150.07 -49.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' ILE . 2.4 tt -150.0 57.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.962 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.82 -48.76 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.83 159.3 16.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.0 p90 -164.25 -178.1 5.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -146.95 136.88 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.0 129.83 37.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.811 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mm -98.86 124.59 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.738 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 4.2 p -118.47 -176.24 3.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.8 mmm -89.76 136.91 28.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -31.01 122.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.755 2.97 . . . . 0.0 112.77 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.02 -10.02 51.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.331 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.85 108.85 19.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.716 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -166.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.51 -176.85 18.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.545 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.01 -35.04 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.14 25.36 10.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.068 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.6 OUTLIER 59.54 78.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.758 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -160.47 42.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 37' ' ' GLU . 12.8 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -108.57 -33.79 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 -17.0 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.274 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.86 100.01 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 49.8 Cg_endo -68.68 -9.52 26.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.51 2.14 . . . . 0.0 112.738 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 33.4 m -48.92 170.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.807 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -102.43 -48.04 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -90.04 -91.86 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.28 36.37 0.67 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.687 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -72.22 172.3 10.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.504 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -96.88 178.61 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 15' ' ' THR . 13.8 t -95.78 155.83 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.69 79.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.41 158.62 22.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.81 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.1 mm100 -144.42 -82.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -146.85 83.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.996 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.67 -35.59 4.33 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.94 157.31 16.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 13.3 t80 -158.63 144.38 16.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 5.6 mt-30 -150.05 149.8 30.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.16 127.82 54.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.777 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.9 mm -89.73 122.2 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -128.38 -158.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.421 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.479 ' HB3' ' CD2' ' A' ' 31' ' ' TYR . 8.1 tpt -89.62 133.13 34.96 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.381 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.5 Cg_exo -30.26 115.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.659 2.906 . . . . 0.0 113.003 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.2 23.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.21 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 27.6 m-85 -89.82 75.92 7.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.566 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.92 -175.73 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.663 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.41 -115.66 3.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 35' ' ' TYR . 11.4 m -138.36 -45.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 111.411 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 34' ' ' VAL . 11.9 m-85 -127.69 31.93 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.178 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.1 t 59.41 85.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.876 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.824 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -175.32 34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.132 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' C ' ' A' ' 37' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.828 0.347 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -94.73 -32.05 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.1 p -136.12 12.6 3.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.306 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.18 118.15 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.9 Cg_endo -74.77 -16.7 20.68 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.466 2.111 . . . . 0.0 112.364 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.0 m -57.91 -166.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 -42.01 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.571 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -89.95 -88.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.208 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.12 43.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.978 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -95.84 158.28 15.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.9 158.36 15.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.714 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.03 148.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.35 74.33 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.716 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.7 t0 -95.34 131.12 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.656 ' HB3' HD12 ' A' ' 20' ' ' ILE . 14.8 mt-30 -125.4 -68.26 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -127.59 72.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -54.8 4.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -90.02 162.2 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 46.3 p90 -157.73 179.83 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 141.01 22.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 1.7 m -89.84 133.9 34.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.14 123.07 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.9 p -119.75 -168.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.444 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 9.4 mmm -89.58 131.88 38.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 2.9 Cg_exo -34.93 97.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.432 2.754 . . . . 0.0 112.645 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.92 -13.3 4.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.374 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.85 106.94 18.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.98 -168.23 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.82 -175.95 16.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.0 -29.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -128.7 30.55 5.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.2 m 60.79 91.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE2' HD11 ' A' ' 38' ' ' ILE . 1.8 pp20? -169.73 33.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 37' ' ' GLU . 16.2 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 0.0 111.088 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.5 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.78 0.324 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -101.29 -31.95 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -104.93 -30.78 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.83 91.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 23' ' ' PHE . 69.6 Cg_exo -51.59 -22.25 12.46 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.535 2.157 . . . . 0.0 112.578 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.9 m -45.95 164.26 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -109.91 -40.57 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -89.83 -94.14 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -150.24 41.07 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.07 171.78 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.375 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -97.1 174.1 6.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 15' ' ' THR . 43.4 t -105.44 133.92 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.014 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.69 65.75 1.4 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -108.48 37.09 2.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -117.28 30.84 7.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.287 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 20' ' ' ILE . 22.3 mt -150.05 49.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.033 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.32 -59.46 3.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.25 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -107.75 162.45 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.563 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' CE2' ' HG2' ' A' ' 9' ' ' PRO . 48.8 t80 -106.31 146.58 30.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.29 134.91 17.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.003 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 m -89.85 125.89 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.1 mm -89.53 121.23 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 21.2 p -132.55 -162.68 1.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.015 0.436 . . . . 0.0 111.875 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.528 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.71 134.87 31.41 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.001 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 6.2 Cg_endo -48.17 85.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.0 112.342 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 165.5 -29.63 0.21 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.24 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -89.89 104.98 17.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.92 -168.36 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.816 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 114.3 -164.03 12.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 m -92.05 -31.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 14.7 m-85 -122.5 24.38 9.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.44 90.15 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.212 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.844 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER 176.52 33.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.523 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 37' ' ' GLU . 2.1 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.756 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -35.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -135.55 8.16 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.87 101.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.574 0.226 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 66.3 Cg_endo -72.74 -5.85 17.94 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.485 2.124 . . . . 0.0 112.759 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.7 m -56.23 -171.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -113.52 -58.74 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.991 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -89.65 -145.47 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.454 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.56 54.77 3.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.046 0.451 . . . . 0.0 110.636 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -98.27 172.2 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.65 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' H ' HG22 ' A' ' 15' ' ' THR . 31.3 p -100.17 152.68 19.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 tp -163.31 78.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 25.4 t0 -112.55 136.17 52.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -97.57 -69.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 21' ' ' GLY . 18.1 pt -140.28 -42.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.392 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' N ' HG13 ' A' ' 20' ' ' ILE . . . -134.83 -35.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.923 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -89.78 121.16 31.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 7.1 t80 -100.24 147.19 26.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.765 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.413 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 tt0 -145.88 141.24 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 m -115.54 134.25 55.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.73 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.3 mm -89.77 121.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 p -130.03 -166.7 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.382 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -89.64 135.45 30.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.844 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 4.6 Cg_exo -38.96 121.65 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.044 2.496 . . . . 0.0 112.386 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.31 -16.42 27.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.233 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -89.84 88.85 7.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 110.492 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.9 -179.61 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.268 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.934 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 122.68 -158.06 17.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.534 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.91 -32.57 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -135.66 28.17 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.676 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.83 86.31 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.836 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -177.11 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.934 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.556 0.217 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.05 -32.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 111.252 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -115.39 -13.68 11.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.632 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 63.4 97.88 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.659 0.266 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 57.3 Cg_endo -69.68 -12.93 34.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.575 2.183 . . . . 0.0 112.775 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 9.9 m -57.64 -169.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -114.47 -54.84 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -89.77 -141.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.491 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.0 38.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 111.18 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -76.01 169.97 17.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.45 169.63 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 p -102.56 136.49 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.69 87.06 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -113.28 164.53 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.777 ' HB3' HD12 ' A' ' 20' ' ' ILE . 23.5 mt-30 -147.55 -65.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.4 mp -139.44 -54.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 26.82 1.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.52 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.56 88.82 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 44.5 t80 -90.27 145.38 25.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.06 152.37 34.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 m -113.99 129.98 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.76 121.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 p -128.75 -167.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.393 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.43 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.5 mmm -89.78 130.43 42.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.223 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.43 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 3.8 Cg_exo -38.81 98.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 112.285 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.31 -11.55 3.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.398 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -89.72 104.34 16.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -178.42 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.96 -172.37 15.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.82 -30.49 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -124.83 28.29 6.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m 60.26 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.673 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -158.72 37.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 37' ' ' GLU . 26.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.828 0.347 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.41 -36.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -122.51 -2.79 8.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.503 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 60.12 103.48 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 110.743 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 46.3 Cg_endo -68.75 -9.27 25.72 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.342 2.028 . . . . 0.0 112.828 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.7 m -58.01 -165.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -134.64 -43.32 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -89.64 -86.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.128 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -150.13 27.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.3 155.94 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.268 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -94.96 178.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' H ' HG22 ' A' ' 15' ' ' THR . 31.5 p -105.96 142.75 35.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.67 87.85 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 7.3 t70 -125.96 78.93 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -150.26 25.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.11 35.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.43 10.04 59.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.646 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.19 151.39 32.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.722 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 5.3 t80 -117.77 133.94 55.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.75 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -150.18 139.42 21.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 m -89.88 133.9 34.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 mm -92.74 120.84 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.721 0.296 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 8.3 p -115.65 -166.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.376 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.401 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -89.82 148.47 39.91 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 10.3 Cg_endo -50.79 93.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.804 2.336 . . . . 0.0 111.864 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.42 -8.52 5.32 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -89.82 121.66 32.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.682 0.277 . . . . 0.0 110.428 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -107.64 -165.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.33 -166.64 12.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.473 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 35' ' ' TYR . 33.0 m -89.8 -43.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.819 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-85 -113.12 32.52 5.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.018 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER 56.64 80.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.671 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -159.46 44.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.462 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 37' ' ' GLU . 19.2 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 98.3 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.842 0.353 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.3 -32.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -122.62 12.94 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.346 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.05 109.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.608 0.242 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 56.8 Cg_endo -69.88 -9.58 26.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.367 2.044 . . . . 0.0 112.529 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.4 m -57.87 -166.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.93 -41.58 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.322 . . . . 0.0 111.496 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.8 -88.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.052 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.19 29.79 0.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.66 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -78.6 156.49 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -89.94 167.04 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -103.64 136.69 42.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 17' ' ' LEU . 6.4 tt -133.0 80.28 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 8.6 t0 -93.15 138.92 31.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.64 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.5 mt-30 -124.17 -73.97 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 19' ' ' GLN . 2.8 mp -132.67 69.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.8 -44.37 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.0 158.01 16.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 26.9 p90 -155.38 -179.47 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -148.07 142.01 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.832 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.26 125.65 36.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.0 mm -89.87 122.53 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.657 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 p -124.32 -164.72 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.487 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.6 136.73 29.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.51 97.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.116 2.544 . . . . 0.0 112.457 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.65 -13.98 4.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.236 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.78 106.24 18.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.1 179.67 4.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.901 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 125.41 -160.77 19.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.374 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 m -89.96 -32.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.352 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.58 29.45 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.753 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.37 82.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.829 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -172.15 32.94 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.901 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.831 0.348 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.57 -30.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -139.84 22.58 2.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 60.87 115.17 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . 84.7 Cg_endo -75.69 -14.17 19.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.196 . . . . 0.0 112.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -50.59 174.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -110.22 -44.41 3.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.348 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -89.98 -90.33 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.076 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -150.29 33.28 0.65 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.701 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -75.81 158.89 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.326 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -93.92 152.43 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.81 138.2 31.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.16 90.08 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 10.8 p30 -89.79 147.68 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -129.49 -75.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.22 66.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.22 -27.37 17.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.469 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -122.79 147.03 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 5.4 p90 -134.58 -175.41 3.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 138.0 20.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 m -89.79 126.62 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.629 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.79 121.28 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -129.14 -165.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.177 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.63 135.6 30.55 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.8 Cg_endo -41.28 103.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.101 2.534 . . . . 0.0 112.617 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.07 -11.0 5.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.494 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.85 95.49 10.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.733 0.301 . . . . 0.0 110.642 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.52 -167.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.7 -155.31 17.3 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.434 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.85 -32.09 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.746 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 13.9 m-85 -135.6 50.0 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.29 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 16.8 p 43.76 51.78 6.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.602 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.4 pp20? -122.35 37.22 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 37' ' ' GLU . 28.8 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.029 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.655 0.264 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.07 -36.59 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.3 m -105.78 -7.96 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.285 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 62.03 91.45 0.08 OUTLIER Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.069 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 37.0 Cg_endo -65.64 -19.21 59.97 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.53 2.154 . . . . 0.0 112.248 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.45 -169.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -113.35 -59.18 2.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -89.86 -146.42 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.39 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.85 48.41 1.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -80.99 176.6 9.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.077 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -117.06 143.0 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 31.7 p -89.93 134.76 34.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 86.27 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.92 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -118.75 156.86 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 21' ' ' GLY . 4.1 tt -135.5 -45.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.286 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -155.26 36.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.618 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -149.82 117.15 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 22.8 t80 -120.89 136.6 54.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -150.06 132.05 15.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 m -90.78 123.09 34.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.491 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.8 mm -89.82 122.64 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.61 -167.84 1.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.578 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.446 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 13.1 mmm -89.7 130.9 41.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.306 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.9 Cg_exo -38.13 92.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.286 2.657 . . . . 0.0 112.363 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.45 -17.5 1.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.364 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 66.4 m-85 -89.72 109.12 20.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.12 -176.23 3.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.11 -160.25 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.418 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.83 -32.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 110.732 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 1.8 m-85 -129.5 30.9 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.629 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.1 m 61.19 81.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.711 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -160.52 39.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.3 mm . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.811 0.339 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 t -80.85 149.89 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -155.9 -46.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -31.14 14.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.6 m -97.41 40.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.924 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.17 -27.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.6 p -110.97 -23.0 11.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.29 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 51.1 Cg_exo -55.13 -20.15 23.11 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.665 2.243 . . . . 0.0 112.569 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -48.71 171.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.624 0.249 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -39.01 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 111.682 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -89.9 -89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -150.19 35.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 110.982 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -84.2 160.89 20.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -176.08 3.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.56 153.6 19.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.798 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.057 HD13 HD11 ' A' ' 26' ' ' ILE . 3.1 tt -161.23 89.67 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 5.4 t0 -139.72 138.85 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.29 -59.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -143.34 -45.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.25 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -151.64 39.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.591 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -149.99 79.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.792 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 3.8 t80 -89.53 130.86 35.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -150.22 139.0 20.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 m -89.77 133.09 34.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.057 HD11 HD13 ' A' ' 17' ' ' LEU . 31.9 mm -89.85 122.38 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.588 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 25.8 p -129.67 -164.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 111.572 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.57 ' HE2' ' HG2' ' A' ' 29' ' ' PRO . 3.7 tpt -89.7 140.44 28.02 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.502 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HG2' ' HE2' ' A' ' 28' ' ' MET . 9.2 Cg_endo -50.53 89.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.098 2.532 . . . . 0.0 111.828 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.86 -20.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -89.63 122.63 32.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.738 0.304 . . . . 0.0 110.366 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -102.46 -174.85 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.87 -173.84 15.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.475 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.85 -30.59 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 110.914 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.42 25.74 8.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.947 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.8 OUTLIER 60.41 90.16 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.697 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.746 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -177.0 42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.746 HD13 ' O ' ' A' ' 37' ' ' GLU . 13.8 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.13 139.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.044 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -59.78 174.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' OE2' ' CE2' ' A' ' 23' ' ' PHE . 4.8 mm-40 -129.72 31.51 4.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.978 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.94 19.31 1.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 tt -114.33 21.38 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.302 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 m -150.1 -42.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.155 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.4 88.97 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.745 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 59.4 Cg_endo -71.92 -5.67 17.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.746 2.297 . . . . 0.0 112.9 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.1 m -56.71 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -125.26 -43.61 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 -91.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.061 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.12 31.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.53 165.45 22.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.497 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.42 171.13 8.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.74 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 p -92.24 153.84 19.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.111 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -158.02 77.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.7 t70 -126.57 142.11 51.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -150.07 -71.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.53 38.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.188 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 11.96 61.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.778 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.71 70.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.658 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 2.0 t80 -76.91 129.52 36.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.191 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.32 136.03 18.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.6 m -93.1 139.99 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.342 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.3 mm -99.05 121.27 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 2.1 p -124.06 -170.72 2.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.208 0.528 . . . . 0.0 112.099 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.457 ' HE3' ' HD2' ' A' ' 29' ' ' PRO . 1.6 mtp -89.65 160.49 41.44 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.424 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD2' ' HE3' ' A' ' 28' ' ' MET . 9.8 Cg_endo -50.07 125.0 13.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.928 2.419 . . . . 0.0 111.668 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.19 -5.67 63.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.405 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -89.79 104.59 17.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.73 0.3 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.73 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.342 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.09 -169.86 13.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.431 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -89.65 -29.91 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.768 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -126.61 29.06 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.712 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.4 m 60.98 91.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.565 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.658 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.1 pp20? -177.36 42.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.056 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.7 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.103 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.868 0.366 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 5' ' ' CYS . 21.5 t -88.85 103.18 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -94.0 11.1 30.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.276 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.92 -44.24 6.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.704 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.459 ' H ' HG12 ' A' ' 2' ' ' VAL . 85.5 m -100.79 29.86 4.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.908 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 tt -92.41 -30.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.8 t -116.18 17.36 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.32 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 53.94 97.55 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 65.4 Cg_endo -72.43 -16.77 27.44 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.506 2.138 . . . . 0.0 112.506 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 14.3 m -56.55 -169.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -57.65 2.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.76 -145.88 0.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.76 53.34 2.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -88.95 -178.96 5.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.234 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -124.89 140.29 53.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -89.96 145.32 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 tp -141.41 87.8 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.013 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 14.7 t70 -90.01 150.5 22.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 20' ' ' ILE . 16.8 mt-30 -126.92 -60.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.645 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -137.95 -63.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.837 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.17 4.52 5.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.805 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -150.22 162.33 40.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.856 0.36 . . . . 0.0 110.971 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.69 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 33.1 p90 -148.82 -177.1 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.8 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 138.77 29.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.765 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 m -93.75 123.68 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.075 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.413 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.1 mm -89.81 122.62 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.547 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -129.1 -165.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 111.355 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.526 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.0 mmm -89.84 128.16 51.27 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.526 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.0 Cg_endo -40.82 93.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.945 2.43 . . . . 0.0 112.267 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.04 -18.79 1.76 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.375 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.74 96.39 10.67 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.77 0.319 . . . . 0.0 110.421 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -174.89 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.47 -159.36 14.75 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.261 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 m -89.87 -36.24 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -126.52 30.57 5.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.577 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 62.66 76.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.6 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -150.9 41.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.8 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.906 0.384 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 t -97.46 84.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -107.9 -47.25 3.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.06 -32.13 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -95.77 35.34 1.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 tp -95.56 -32.2 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -144.76 15.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.389 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.98 112.31 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.58 0.229 . . . . 0.0 111.158 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 69.6 Cg_endo -73.58 -18.05 22.9 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.431 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.7 m -63.04 -175.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.39 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -55.52 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -89.33 -168.43 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.81 52.49 2.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.05 176.73 4.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 m -89.96 165.28 14.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.32 123.15 37.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.968 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.69 HD12 HD11 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -146.86 87.19 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 31.7 t70 -135.81 161.24 36.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.41 -65.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 21' ' ' GLY . 3.1 tt -150.08 -46.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.268 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -123.77 -33.85 0.78 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.725 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.88 106.66 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.99 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 9.7 t80 -113.06 121.51 44.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.09 141.18 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.972 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.407 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 1.7 m -105.32 155.68 18.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.593 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 17' ' ' LEU . 31.1 mm -89.8 120.59 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.046 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 p -120.98 -170.63 2.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.562 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.455 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 8.3 mmm -89.86 129.95 44.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.114 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 4.5 Cg_exo -38.81 91.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.176 2.584 . . . . 0.0 112.371 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 150.34 -24.14 1.09 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.107 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 17.1 m-30 -89.84 83.86 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.823 0.344 . . . . 0.0 110.469 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -90.06 -177.1 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.845 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.11 -154.86 16.28 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.565 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.7 m -89.91 -30.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 1.1 m-85 -131.24 31.36 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m 54.47 74.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.837 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -166.93 30.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.149 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.845 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.8 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.739 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.14 91.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -79.26 80.19 5.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.06 -71.55 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 m -122.49 29.21 7.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -103.45 -33.1 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.004 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -117.76 -13.32 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.454 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.62 97.36 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.61 0.243 . . . . 0.0 110.82 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -66.35 -12.95 37.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.487 2.125 . . . . 0.0 112.638 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 21.3 m -55.85 175.76 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.757 0.313 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -102.82 -59.44 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.76 -145.4 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.418 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.76 50.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.939 0.399 . . . . 0.0 110.827 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -91.26 158.62 16.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.07 163.07 15.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.2 p -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tt -142.65 96.54 2.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 27.7 t0 -128.06 131.79 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.51 -74.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.96 73.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.35 -29.51 11.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.591 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.96 134.71 34.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.1 t80 -134.92 141.13 46.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.975 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -150.08 131.45 14.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.0 m -98.86 129.87 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 25.7 mm -89.83 121.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.2 p -126.93 -167.03 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.414 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 10.1 tpt -89.71 120.43 69.48 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.34 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 83.9 Cg_exo -33.55 95.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.223 2.615 . . . . 0.0 112.725 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.61 -12.83 2.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.52 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 28' ' ' MET . 38.9 m-85 -89.72 107.37 19.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.828 0.346 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -175.31 4.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.361 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.5 -166.63 12.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.41 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.82 -32.37 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.669 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -128.23 29.08 5.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.537 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 57.4 m 61.09 76.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB3' ' CB ' ' A' ' 11' ' ' GLN . 1.8 pp20? -141.1 28.77 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.4 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.64 124.54 40.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.509 ' H ' HD11 ' A' ' 6' ' ' ILE . 1.6 m-20 -97.91 -171.36 2.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.33 -31.1 11.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.9 m -96.1 61.76 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.509 HD11 ' H ' ' A' ' 3' ' ' ASN . 31.8 mm -91.66 -40.29 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -138.79 18.61 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 m120 57.08 104.37 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.071 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 57.1 Cg_endo -70.08 -19.22 34.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.474 2.116 . . . . 0.0 112.342 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 14.1 m -54.64 -178.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.859 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -107.77 -58.43 1.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.07 0.462 . . . . 0.0 110.975 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -89.81 -144.94 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.508 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.81 51.94 2.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -97.42 147.59 24.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 m -90.39 157.8 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 26.5 p -91.61 151.11 20.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 87.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 17.6 t0 -127.52 150.25 49.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -132.98 -54.3 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 21' ' ' GLY . 2.1 pp -149.42 -46.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.63 ' N ' HD12 ' A' ' 20' ' ' ILE . . . -150.82 34.75 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.529 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -150.01 108.99 3.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 4.3 t80 -114.68 135.43 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.99 130.38 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.863 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.0 m -90.45 130.25 36.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.88 123.33 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.446 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.27 -169.72 2.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.437 . . . . 0.0 111.629 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.466 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 9.0 mmm -89.97 129.41 46.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.004 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 2.9 Cg_endo -39.63 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.2 2.6 . . . . 0.0 112.421 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 152.99 -25.7 0.81 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.25 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.1 m-30 -89.79 111.91 23.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.666 0.269 . . . . 0.0 110.463 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -110.6 -175.97 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.149 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.06 -151.4 17.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.91 -31.95 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 0.0 110.922 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.7 m-85 -133.77 28.85 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.725 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.65 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.634 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.68 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.4 pp20? -171.0 40.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.001 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.3 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.038 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.12 132.84 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -170.57 150.14 3.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 31.23 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.1 23.53 13.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.831 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.11 -35.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.148 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -106.77 -20.1 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m120 62.76 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.764 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 44.7 Cg_endo -68.3 -9.74 26.81 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.84 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 15.8 m -58.85 -163.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -132.08 -45.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.709 0.29 . . . . 0.0 111.681 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -90.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -150.12 29.04 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 110.67 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -70.1 162.34 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.273 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 171.41 9.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.781 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.88 124.59 49.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.89 89.14 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -113.48 168.58 9.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -150.08 -65.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.715 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 21' ' ' GLY . 7.7 tp -150.16 -45.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -133.83 -33.52 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.891 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -89.77 152.3 21.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.057 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 11.5 t80 -155.79 139.35 15.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.19 138.87 20.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.0 m -89.94 141.04 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.456 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 27.6 mm -99.51 122.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.652 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 5.2 p -119.06 -171.44 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.687 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 12.0 mmm -89.8 132.1 37.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.903 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 5.7 Cg_exo -36.49 92.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.383 2.722 . . . . 0.0 112.454 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.26 -23.28 1.56 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.184 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -89.8 122.88 33.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 110.418 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -164.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.113 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.38 -171.79 14.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.436 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.91 -32.86 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.48 24.19 11.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.968 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.33 81.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.645 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -175.18 49.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.283 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 37' ' ' GLU . 14.6 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.878 0.371 . . . . 0.0 111.179 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -70.97 136.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -151.41 -58.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.97 28.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 54.2 m -111.14 22.98 14.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.93 -31.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.24 -21.83 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 66.11 105.88 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 80.2 Cg_endo -75.47 -25.33 11.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.604 2.203 . . . . 0.0 112.179 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 14' ' ' ALA . 6.2 m -51.35 165.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.759 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -101.02 -56.44 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.107 0.479 . . . . 0.0 111.101 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -89.68 -143.39 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.74 59.65 4.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.859 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . . . -107.91 151.32 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.975 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -95.89 167.1 11.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 p -95.43 157.52 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.801 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -149.12 87.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -120.93 138.63 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -122.91 -78.94 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -150.06 30.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.235 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.68 -37.91 0.54 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.584 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.92 133.63 34.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 110.977 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 2.0 t80 -135.94 124.43 23.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -150.15 141.23 23.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 135.41 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.725 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.466 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.2 mm -96.25 123.08 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.595 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 7.3 p -126.99 -165.36 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.521 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.64 136.56 29.41 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.328 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.521 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.96 103.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.97 2.447 . . . . 0.0 112.374 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.13 -20.94 3.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.128 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.89 112.69 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.278 . . . . 0.0 110.252 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.29 -165.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -168.54 12.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.263 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.4 m -89.88 -29.97 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.798 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.6 m-85 -125.23 27.85 6.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 61.21 86.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.732 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.76 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -174.54 41.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 37' ' ' GLU . 15.6 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.213 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.812 0.339 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.43 86.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -118.09 33.24 5.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 -38.45 11.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.1 m -98.05 30.05 3.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.45 -31.16 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.51 -27.76 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 63.57 95.64 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 58.4 Cg_endo -70.47 -14.1 33.5 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.0 m -56.49 -173.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.741 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 3.6 tm0? -106.55 -60.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.077 0.465 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -89.75 -147.18 0.18 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.5 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.68 59.56 4.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.042 0.448 . . . . 0.0 110.684 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -88.85 177.18 6.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.131 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.3 177.68 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.788 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.428 ' H ' HG22 ' A' ' 15' ' ' THR . 40.3 t -102.57 149.4 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 72.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -108.26 145.32 34.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -122.65 -72.26 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.3 -66.72 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.99 -27.83 3.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.589 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.94 159.01 17.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 53.1 t80 -146.35 145.88 30.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -144.44 157.92 44.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.93 127.87 53.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mm -89.87 122.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.442 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.3 p -128.04 -168.18 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.581 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 9.7 mmm -89.83 129.88 44.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.033 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 3.5 Cg_exo -38.94 91.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.198 2.599 . . . . 0.0 112.383 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.29 -26.3 0.98 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.134 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 9.2 m-30 -89.85 117.86 29.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.788 0.327 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -118.08 -175.62 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.894 0.378 . . . . 0.0 111.203 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.44 -152.52 16.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.86 -31.27 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.936 0.398 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -132.26 28.97 4.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.52 90.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -170.86 35.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 37' ' ' GLU . 29.4 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.054 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.19 112.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -89.19 95.09 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -100.41 -32.86 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 62.8 m -98.18 29.09 3.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -97.97 -34.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -101.91 -29.94 11.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 62.51 115.75 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 68.5 Cg_endo -82.44 1.54 9.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.699 2.266 . . . . 0.0 112.316 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 m -60.13 -165.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.773 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.12 -45.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.142 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -89.98 -88.08 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -150.27 30.19 0.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.763 0.315 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.52 168.41 17.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -101.08 -165.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' H ' HG22 ' A' ' 15' ' ' THR . 47.4 t -129.23 146.2 51.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -160.71 100.66 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.616 ' HA ' ' CB ' ' A' ' 23' ' ' PHE . 4.8 p-10 -92.48 176.01 6.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -147.22 -62.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 pt -149.69 77.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.047 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.07 -48.05 2.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.37 163.14 13.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 110.819 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 18' ' ' ASP . 1.8 p90 -155.78 -179.64 8.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -147.68 155.03 41.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.081 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' C ' HD12 ' A' ' 26' ' ' ILE . 18.8 m -89.39 141.65 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.825 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 26' ' ' ILE . 1.3 mp -101.49 128.4 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.533 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.8 p -118.49 -171.6 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.152 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.427 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 3.0 tpt -89.61 137.12 28.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.9 Cg_exo -36.98 104.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.172 2.581 . . . . 0.0 112.753 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.87 -9.76 7.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.512 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.89 111.95 23.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.661 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.03 -168.15 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.75 176.07 21.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.447 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.02 -29.85 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.307 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.5 m-85 -117.68 24.92 10.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.0 OUTLIER 57.74 82.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.748 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -165.96 42.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 37' ' ' GLU . 16.4 mm . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.159 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.03 127.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -106.96 139.88 40.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -96.37 -27.46 14.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.023 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.3 m -97.07 36.4 1.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -97.82 -33.14 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -5.35 11.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.325 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 63.04 118.92 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.82 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.2 Cg_endo -75.92 -22.06 13.6 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.533 2.156 . . . . 0.0 112.408 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.1 m -58.84 -164.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.15 -43.43 0.96 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.401 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -89.88 -88.42 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.082 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -150.24 27.28 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -69.91 156.92 38.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.5 m -90.0 145.29 25.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 p -90.24 135.37 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tp -127.36 79.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.694 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.2 t0 -95.97 157.97 15.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.504 ' CD ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -150.07 -49.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' ILE . 2.4 tt -150.0 57.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.962 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.82 -48.76 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.83 159.3 16.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.0 p90 -164.25 -178.1 5.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.056 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -146.95 136.88 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.085 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.0 129.83 37.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.811 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mm -98.86 124.59 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.738 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 4.2 p -118.47 -176.24 3.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 111.341 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.8 mmm -89.76 136.91 28.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -31.01 122.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.755 2.97 . . . . 0.0 112.77 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.02 -10.02 51.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.331 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.85 108.85 19.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 110.716 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -166.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.51 -176.85 18.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.545 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.01 -35.04 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.14 25.36 10.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.068 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.6 OUTLIER 59.54 78.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.758 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -160.47 42.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 37' ' ' GLU . 12.8 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.88 0.372 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.0 t -69.15 126.31 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -97.4 42.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 3.6 tp10 -98.94 -37.99 9.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -100.97 27.68 5.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -108.57 -33.79 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 -17.0 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.274 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.86 100.01 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 49.8 Cg_endo -68.68 -9.52 26.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.51 2.14 . . . . 0.0 112.738 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 33.4 m -48.92 170.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.807 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -102.43 -48.04 4.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 111.321 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -90.04 -91.86 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.055 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.28 36.37 0.67 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.687 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -72.22 172.3 10.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.222 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.504 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -96.88 178.61 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 15' ' ' THR . 13.8 t -95.78 155.83 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.69 79.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.41 158.62 22.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.81 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.1 mm100 -144.42 -82.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.81 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -146.85 83.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.996 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.67 -35.59 4.33 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.444 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.94 157.31 16.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 13.3 t80 -158.63 144.38 16.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 5.6 mt-30 -150.05 149.8 30.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -108.16 127.82 54.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.777 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 32.9 mm -89.73 122.2 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.499 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -128.38 -158.27 0.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.421 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.479 ' HB3' ' CD2' ' A' ' 31' ' ' TYR . 8.1 tpt -89.62 133.13 34.96 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.381 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 69.5 Cg_exo -30.26 115.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.659 2.906 . . . . 0.0 113.003 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.2 23.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.21 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 27.6 m-85 -89.82 75.92 7.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.566 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.92 -175.73 4.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.663 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 119.41 -115.66 3.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 35' ' ' TYR . 11.4 m -138.36 -45.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 111.411 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 34' ' ' VAL . 11.9 m-85 -127.69 31.93 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.178 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.1 t 59.41 85.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.876 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.824 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -175.32 34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.132 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' C ' ' A' ' 37' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.61 125.96 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.193 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 59.58 28.84 18.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -143.16 -48.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.806 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.6 m -103.73 29.37 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -94.73 -32.05 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.1 p -136.12 12.6 3.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.306 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.18 118.15 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.9 Cg_endo -74.77 -16.7 20.68 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.466 2.111 . . . . 0.0 112.364 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.0 m -57.91 -166.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 -42.01 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.571 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.3 m-20 -89.95 -88.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.208 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.12 43.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.978 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -95.84 158.28 15.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.9 158.36 15.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.714 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.03 148.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -139.35 74.33 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.716 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 28.7 t0 -95.34 131.12 41.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.656 ' HB3' HD12 ' A' ' 20' ' ' ILE . 14.8 mt-30 -125.4 -68.26 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.656 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.5 mp -127.59 72.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -54.8 4.87 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -90.02 162.2 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.843 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 46.3 p90 -157.73 179.83 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 141.01 22.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 1.7 m -89.84 133.9 34.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.14 123.07 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 1.9 p -119.75 -168.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.444 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 9.4 mmm -89.58 131.88 38.67 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 28' ' ' MET . 2.9 Cg_exo -34.93 97.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.432 2.754 . . . . 0.0 112.645 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.92 -13.3 4.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.374 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.85 106.94 18.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -89.98 -168.23 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.82 -175.95 16.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.564 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.0 -29.89 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -128.7 30.55 5.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 1.2 m 60.79 91.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE2' HD11 ' A' ' 38' ' ' ILE . 1.8 pp20? -169.73 33.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 37' ' ' GLU . 16.2 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 0.0 111.088 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.3 p -70.38 65.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -124.74 129.68 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -109.71 -29.49 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.968 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.5 m -97.84 30.02 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.99 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -101.29 -31.95 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -104.93 -30.78 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m120 61.83 91.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 23' ' ' PHE . 69.6 Cg_exo -51.59 -22.25 12.46 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.535 2.157 . . . . 0.0 112.578 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.9 m -45.95 164.26 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' CG ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -109.91 -40.57 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -89.83 -94.14 0.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -150.24 41.07 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.915 0.388 . . . . 0.0 110.643 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.773 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.07 171.78 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.375 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -97.1 174.1 6.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 15' ' ' THR . 43.4 t -105.44 133.92 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.014 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.69 65.75 1.4 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -108.48 37.09 2.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -117.28 30.84 7.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.287 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 20' ' ' ILE . 22.3 mt -150.05 49.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.033 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.32 -59.46 3.64 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.25 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -107.75 162.45 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.563 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' CE2' ' HG2' ' A' ' 9' ' ' PRO . 48.8 t80 -106.31 146.58 30.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.29 134.91 17.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.003 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 m -89.85 125.89 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 32.1 mm -89.53 121.23 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 21.2 p -132.55 -162.68 1.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.015 0.436 . . . . 0.0 111.875 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.528 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.71 134.87 31.41 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.001 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 6.2 Cg_endo -48.17 85.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.0 112.342 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' MET . . . 165.5 -29.63 0.21 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.24 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -89.89 104.98 17.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.92 -168.36 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.751 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.816 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 114.3 -164.03 12.11 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 m -92.05 -31.56 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 14.7 m-85 -122.5 24.38 9.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.5 OUTLIER 60.44 90.15 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.212 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.844 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER 176.52 33.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.523 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 37' ' ' GLU . 2.1 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.756 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' O ' HG12 ' A' ' 2' ' ' VAL . 21.0 t -97.74 35.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 59.2 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.24 -56.81 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.01 29.75 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -35.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -135.55 8.16 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.578 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.87 101.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.574 0.226 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 66.3 Cg_endo -72.74 -5.85 17.94 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.485 2.124 . . . . 0.0 112.759 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.7 m -56.23 -171.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -113.52 -58.74 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.991 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -89.65 -145.47 0.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.454 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.56 54.77 3.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.046 0.451 . . . . 0.0 110.636 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -98.27 172.2 7.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.211 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -109.65 174.44 5.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' H ' HG22 ' A' ' 15' ' ' THR . 31.3 p -100.17 152.68 19.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 tp -163.31 78.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 25.4 t0 -112.55 136.17 52.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -97.57 -69.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 21' ' ' GLY . 18.1 pt -140.28 -42.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.392 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' N ' HG13 ' A' ' 20' ' ' ILE . . . -134.83 -35.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.923 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -89.78 121.16 31.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 7.1 t80 -100.24 147.19 26.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.765 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.413 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 tt0 -145.88 141.24 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 m -115.54 134.25 55.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.73 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.3 mm -89.77 121.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.9 p -130.03 -166.7 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.382 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.518 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -89.64 135.45 30.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.844 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 4.6 Cg_exo -38.96 121.65 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.044 2.496 . . . . 0.0 112.386 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.31 -16.42 27.1 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.233 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -89.84 88.85 7.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 110.492 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.9 -179.61 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.268 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.934 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 122.68 -158.06 17.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.534 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.91 -32.57 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -135.66 28.17 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.676 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.83 86.31 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.836 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -177.11 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.934 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.45 133.91 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.02 167.2 18.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -113.89 -32.04 6.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.79 15.56 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.05 -32.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 111.252 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -115.39 -13.68 11.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.632 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 63.4 97.88 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.659 0.266 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 57.3 Cg_endo -69.68 -12.93 34.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.575 2.183 . . . . 0.0 112.775 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 9.9 m -57.64 -169.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -114.47 -54.84 2.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -89.77 -141.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.491 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.0 38.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 111.18 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -76.01 169.97 17.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.45 169.63 8.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.2 p -102.56 136.49 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.69 87.06 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -113.28 164.53 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.777 ' HB3' HD12 ' A' ' 20' ' ' ILE . 23.5 mt-30 -147.55 -65.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.4 mp -139.44 -54.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 26.82 1.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.52 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.56 88.82 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 44.5 t80 -90.27 145.38 25.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.06 152.37 34.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.5 m -113.99 129.98 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.76 121.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 p -128.75 -167.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.393 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.43 ' HE3' ' CD ' ' A' ' 29' ' ' PRO . 8.5 mmm -89.78 130.43 42.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.223 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' CD ' ' HE3' ' A' ' 28' ' ' MET . 3.8 Cg_exo -38.81 98.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.1 2.533 . . . . 0.0 112.285 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.31 -11.55 3.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.398 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -89.72 104.34 16.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -178.42 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.96 -172.37 15.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.82 -30.49 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -124.83 28.29 6.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.5 m 60.26 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.673 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.3 pp20? -158.72 37.23 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 37' ' ' GLU . 26.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.0 t0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -90.44 82.57 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -171.51 80.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.6 -62.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.1 m -121.78 25.57 9.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.04 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.41 -36.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -122.51 -2.79 8.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.503 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 60.12 103.48 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 110.743 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 46.3 Cg_endo -68.75 -9.27 25.72 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.342 2.028 . . . . 0.0 112.828 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 21.7 m -58.01 -165.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -134.64 -43.32 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -89.64 -86.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.128 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -150.13 27.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -76.3 155.94 33.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.268 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -94.96 178.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' H ' HG22 ' A' ' 15' ' ' THR . 31.5 p -105.96 142.75 35.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.67 87.85 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 7.3 t70 -125.96 78.93 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -150.26 25.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.11 35.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.43 10.04 59.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.646 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.19 151.39 32.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.722 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 5.3 t80 -117.77 133.94 55.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.75 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -150.18 139.42 21.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 m -89.88 133.9 34.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 mm -92.74 120.84 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.721 0.296 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 8.3 p -115.65 -166.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.376 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.401 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -89.82 148.47 39.91 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 10.3 Cg_endo -50.79 93.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.804 2.336 . . . . 0.0 111.864 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.42 -8.52 5.32 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -89.82 121.66 32.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.682 0.277 . . . . 0.0 110.428 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -107.64 -165.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.125 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.33 -166.64 12.23 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.473 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 35' ' ' TYR . 33.0 m -89.8 -43.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.819 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' N ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-85 -113.12 32.52 5.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.018 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER 56.64 80.51 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.671 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.3 pp20? -159.46 44.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.462 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 37' ' ' GLU . 19.2 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.14 87.38 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.074 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.593 HD22 HD13 ' A' ' 6' ' ' ILE . 1.3 m-20 60.55 -174.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.93 -61.58 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 98.3 m -96.49 40.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.593 HD13 HD22 ' A' ' 3' ' ' ASN . 1.1 tp -94.3 -32.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -122.62 12.94 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.346 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.05 109.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.608 0.242 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 56.8 Cg_endo -69.88 -9.58 26.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.367 2.044 . . . . 0.0 112.529 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.4 m -57.87 -166.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.93 -41.58 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.322 . . . . 0.0 111.496 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.8 -88.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.052 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.19 29.79 0.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.66 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -78.6 156.49 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -89.94 167.04 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -103.64 136.69 42.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 17' ' ' LEU . 6.4 tt -133.0 80.28 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 8.6 t0 -93.15 138.92 31.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.64 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.5 mt-30 -124.17 -73.97 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 19' ' ' GLN . 2.8 mp -132.67 69.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.8 -44.37 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.0 158.01 16.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 26.9 p90 -155.38 -179.47 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -148.07 142.01 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.832 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.26 125.65 36.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.0 mm -89.87 122.53 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.657 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 p -124.32 -164.72 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.487 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.6 136.73 29.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.5 Cg_endo -41.51 97.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.116 2.544 . . . . 0.0 112.457 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.65 -13.98 4.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.236 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.78 106.24 18.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.1 179.67 4.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.901 ' HA3' HD13 ' A' ' 38' ' ' ILE . . . 125.41 -160.77 19.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.374 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 m -89.96 -32.22 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.352 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.58 29.45 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.753 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.37 82.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.829 ' C ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -172.15 32.94 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.901 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.9 mp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.901 0.382 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.31 137.2 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.36 -173.06 2.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.38 -48.42 5.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 m -113.74 82.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.57 -30.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -139.84 22.58 2.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m120 60.87 115.17 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . 84.7 Cg_endo -75.69 -14.17 19.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.196 . . . . 0.0 112.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 23.0 m -50.59 174.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -110.22 -44.41 3.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.348 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -89.98 -90.33 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.076 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -150.29 33.28 0.65 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.701 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -75.81 158.89 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.326 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -93.92 152.43 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.81 138.2 31.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.16 90.08 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 23' ' ' PHE . 10.8 p30 -89.79 147.68 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -129.49 -75.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -137.22 66.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.043 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.22 -27.37 17.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.469 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -122.79 147.03 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.738 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 5.4 p90 -134.58 -175.41 3.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.81 138.0 20.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 m -89.79 126.62 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.629 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mm -89.79 121.28 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -129.14 -165.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.177 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -89.63 135.6 30.55 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' HG2' ' A' ' 28' ' ' MET . 1.8 Cg_endo -41.28 103.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.101 2.534 . . . . 0.0 112.617 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.07 -11.0 5.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.494 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.85 95.49 10.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.733 0.301 . . . . 0.0 110.642 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.52 -167.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.7 -155.31 17.3 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.434 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.85 -32.09 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.746 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 13.9 m-85 -135.6 50.0 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.29 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 16.8 p 43.76 51.78 6.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.602 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.4 pp20? -122.35 37.22 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 37' ' ' GLU . 28.8 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.029 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.853 0.359 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.2 t -93.8 98.21 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -74.09 -168.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.9 -55.07 3.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.54 23.78 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -118.07 -36.59 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.3 m -105.78 -7.96 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.285 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 62.03 91.45 0.08 OUTLIER Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.069 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 23' ' ' PHE . 37.0 Cg_endo -65.64 -19.21 59.97 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.53 2.154 . . . . 0.0 112.248 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -57.45 -169.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -113.35 -59.18 2.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -89.86 -146.42 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.39 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.85 48.41 1.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -80.99 176.6 9.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.077 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -117.06 143.0 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 31.7 p -89.93 134.76 34.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 86.27 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.92 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -118.75 156.86 28.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 21' ' ' GLY . 4.1 tt -135.5 -45.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.286 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -155.26 36.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.618 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -149.82 117.15 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 9' ' ' PRO . 22.8 t80 -120.89 136.6 54.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -150.06 132.05 15.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.9 m -90.78 123.09 34.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.491 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.8 mm -89.82 122.64 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.61 -167.84 1.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.578 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.446 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 13.1 mmm -89.7 130.9 41.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.306 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD2' ' CE ' ' A' ' 28' ' ' MET . 3.9 Cg_exo -38.13 92.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.286 2.657 . . . . 0.0 112.363 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.45 -17.5 1.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.364 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 28' ' ' MET . 66.4 m-85 -89.72 109.12 20.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.732 0.301 . . . . 0.0 110.371 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.12 -176.23 3.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.11 -160.25 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.418 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.83 -32.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 110.732 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 1.8 m-85 -129.5 30.9 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.629 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.1 m 61.19 81.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.711 ' O ' HD13 ' A' ' 38' ' ' ILE . 1.9 pp20? -160.52 39.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.3 mm . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 stop_ save_